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Abstract: Survival of cells within a transplanted skin substitute is dependent on the diffusion of nutrients
and oxygen from the underlying wound site. Thus, formation of mature capillary networks in vitro in the
skin substitute, so called prevascularization, is a promising approach to overcome this limitation. For this
purpose I investigated human adipose-derived stem cells as a novel cell source for the tissue-engineering
of prevascularized skin substitutes. The so called stromal-vascular fraction (SVF) isolated from adipose
tissue is a heterogeneous cell population including mesenchymal and endothelial cells but is depleted from
mature adipocytes. I observed that both endothelial and mesenchymal cells present in the SVF assembled
into a dense, microvascular network when submerged within fibrin hydrogels [1]. I also found that human
tissue-engineered capillaries were already stabilized in vitro by perivascular cells (pericytes) as illustrated
by a staining for pericyte specific markers such as ￿-smooth muscle actin (￿SMA) and neuron-glial antigen
2 (NG2). Most importantly, I demonstrated that SVF-derived capillary networks present in the prevas-
cularized skin substitutes had the potential to connect to the host vasculature (by inosculation) within
3-4 days after transplantation onto the backs of immuno-incompetent rats. In contrast, transplantation
of non-prevascularized controls, lacking endothelial cells, resulted in a delayed ingrowth of rat vessels
and graft perfusion, which was not observed before day 14 after transplantation. Moreover, I examined
the effects associated with rapid graft perfusion in vivo regarding the regeneration of the dermal and
epidermal skin compartment. Skin substitutes prevascularized by cells of the SVF demonstrated an in-
creased graft size after transplantation, as well as an enhanced collagen type I deposition in the dermal
compartment. Furthermore, I evaluated the expression of tissue homeostasis and wound healing markers
in the epidermis. The staining for cytokeratin 16 and 17 (wound healing markers) revealed that the
period of wound healing could be dramatically decreased in the prevascularized skin grafts. Expression
of cytokeratin 19 (skin homeostasis marker) restricted to the basal keratinocyte layer rather than also
expressed in several suprabasal layers, demonstrated that graft prevascularization contributed to a faster
epidermal homeostasis. In the second part of my work, I have characterized different features of tissue-
engineered skin substitutes regarding our future clinical trial. In this regard, I was able to contribute
to the optimization of the protocol for the production of skin substitutes to shorten their total culture
time from 21 to 12 days [2]. Das Überleben der Zellen innerhalb eines transplantierten Haut-Substituts
ist abhängig von adäquater Diffusion von Nährstoffen, Sauerstoff, Wachstumsfaktoren, Zytokinen und
Hormonen ausgehend vom darunter liegenden Wundbett. Deshalb ist die Bildung reifer Kapillarnet-
zwerke in vitro in dem Haut-Substitut (eine sogenannte Prä-Vaskularisierung) ein viel versprechender
Ansatz, um diese Einschränkung zu überwinden. Zu diesem Zweck untersuchte ich die aus menschlichem
Fettgewebe gewonnenen Stammzellen als eine neuartige Zellquelle für das Tissue-Engineering von Haut-
Substituten. Die stromal-vaskuläre-Zellfraktion (SVF) aus dem Fettgewebe ist eine heterogene Zellpop-
ulation die sowohl Mesenchym- als auch Endothelzellen enthält, aber keine reifen Adipozyten mehr.
Die hier dargestellte Arbeit zeigt folgende Befunde: Ich beobachtete erstens, dass die Mesenchymal-
und Endothelzellen der SVF ein dichtes, miteinander kommunizierendes Kapillar-Netzwerk in Fibrin-
Hydrogelen in vitro entwickelt haben [1]. Zweitens konnte ich demonstrieren, dass die menschlichen
engineerten Kapillaren bereits in vitro durch perivaskuläre Zellen (Perizyten) stabilisiert wurden. Dies
wurde durch eine Färbung mit Perizyt-spezifischen Markern wie ￿-Aktin der glatten Muskeln (￿SMA) oder
Neuron-Glia-Antigen 2 (NG2) nachgewiesen. Nach der Transplantation auf immuno-inkompetente Rat-
ten schlossen sich diese Kapillarnetzwerke in den prä-vaskularisierten Haut-Substituten an die Ratten-
Blutgefässe innerhalb von 3-4 Tagen an (Inoskulation). Im Gegensatz dazu war das Einwachsen von
Ratten-Blutgefässen in die nicht prä-vaskularisierten Kontroll-Substitute verzögert. Die Blutperfusion
der gesamten Dermis wurde in vivo erst nach dem 14. Tag beobachtet. Im Übrigen untersuchte ich die
Effekte der schnellen Blutperfusion der prä-vaskularisierten Haut-Substitute auf die epidermale und der-
male Hautregeneration in vivo. Die prä- vaskularisierten Substitute zeigten in vivo eine grössere Fläche
und eine verstärkte Kollagen Typ I-Ablagerung in der Dermis. Weiterhin analysierte ich die Expres-
sion von Homöostase- und Wundheilungs-Markern in der Epidermis. Die Färbung für Zytokeratine 16
und 17 ergab, dass die Wundheilungsperiode in den prä-vaskularisierten Haut-Substituten drastisch ver-
ringert war. Darüber hinaus zeigte eine verminderte Expression von Zytokeratin 19 in den Keratinozyten
der Basalschicht, dass die Prä-Vaskularisierung ebenfalls zu einer schnelleren epidermalen Homöostase
beitrug. Im zweiten Teil meiner Arbeit habe ich verschiedene Merkmale der tissue-engineerten Haut-
Substitute in Hinblick auf unsere zukünftige klinische Anwendung untersucht. Diesbezüglich habe ich
das Protokoll zur Herstellung unserer Haut-Substitute soweit optimiert, dass deren Produktion von 21
auf 12 Tage reduziert werden konnte [2]. Ich habe auch untersucht, ob es möglich ist, in unseren Haut-
Substituten Pigment produzierende Zellen, sogenannte Melanozyten, in die Epidermis zu integrieren [3].
Ein wichtiger Teil dieser Studie war es die Funktion und das Verhalten der Melanozyten, sowie ihre
Interaktionen mit den Keratinozyten in kurz- und langfristigen in vivo Versuchen, zu beobachten. Zu-
dem wurden in diesen Substituten die Innervierung und das Einwachsen von Blut- und Lymphgefässen
systematisch untersucht [4-5].
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1. SUMMARY 
Survival of cells within a transplanted skin substitute is dependent on the diffusion of 
nutrients and oxygen from the underlying wound site. Thus, formation of mature capillary 
networks in vitro in the skin substitute, so called prevascularization, is a promising approach 
to overcome this limitation. For this purpose I investigated human adipose-derived stem cells 
as a novel cell source for the tissue-engineering of prevascularized skin substitutes.  
 The so called stromal-vascular fraction (SVF) isolated from adipose tissue is a 
heterogeneous cell population including mesenchymal and endothelial cells but is depleted 
from mature adipocytes. I observed that both endothelial and mesenchymal cells present in 
the SVF assembled into a dense, microvascular network when submerged within fibrin 
hydrogels [1].  I also found that human tissue-engineered capillaries were already stabilized in 
vitro by perivascular cells (pericytes) as illustrated by a staining for pericyte specific markers 
such as α-smooth muscle actin (αSMA) and neuron-glial antigen 2 (NG2). 
 Most importantly, I demonstrated that SVF-derived capillary networks present in the 
prevascularized skin substitutes had the potential to connect to the host vasculature (by 
inosculation) within 3-4 days after transplantation onto the backs of immuno-incompetent 
rats. In contrast, transplantation of non-prevascularized controls, lacking endothelial cells, 
resulted in a delayed ingrowth of rat vessels and graft perfusion, which was not observed 
before day 14 after transplantation. Moreover, I examined the effects associated with rapid 
graft perfusion in vivo regarding the regeneration of the dermal and epidermal skin 
compartment. Skin substitutes prevascularized by cells of the SVF demonstrated an increased 
graft size after transplantation, as well as an enhanced collagen type I deposition in the dermal 
compartment. Furthermore, I evaluated the expression of tissue homeostasis and wound 
healing markers in the epidermis. The staining for cytokeratin 16 and 17 (wound healing 
markers) revealed that the period of wound healing could be dramatically decreased in the 
prevascularized skin grafts. Expression of cytokeratin 19 (skin homeostasis marker) restricted 
to the basal keratinocyte layer rather than also expressed in several suprabasal layers, 
demonstrated that graft prevascularization contributed to a faster epidermal homeostasis.  
 In the second part of my work, I have characterized different features of tissue-
engineered skin substitutes regarding our future clinical trial. In this regard, I was able to 
contribute to the optimization of the protocol for the production of skin substitutes to shorten 
their total culture time from 21 to 12 days [2]. I have also examined whether it is possible to 
integrate pigment producing melanocytes into the epidermis of tissue-engineered dermo-
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epidermal skin grafts [3]. An important part of this study was to observe the function and 
behaviour of those melanocytes and their interactions with keratinocytes in short- and long-
term in vivo experiments. In addition, I contributed to the investigation of the innervation of 
the afore-mentioned skin grafts in vivo [4-5]. 
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2. ZUSAMMENFASSUNG 
Das Überleben der Zellen innerhalb eines transplantierten Haut-Substituts ist abhängig von 
adäquater Diffusion von Nährstoffen, Sauerstoff, Wachstumsfaktoren, Zytokinen und 
Hormonen ausgehend vom darunter liegenden Wundbett. Deshalb ist die Bildung reifer 
Kapillarnetzwerke in vitro in dem Haut-Substitut (eine sogenannte Prä-Vaskularisierung) ein 
viel versprechender Ansatz, um diese Einschränkung zu überwinden. Zu diesem Zweck 
untersuchte ich die aus menschlichem Fettgewebe gewonnenen Stammzellen als eine 
neuartige Zellquelle für das Tissue-Engineering von Haut-Substituten.  
 Die stromal-vaskuläre-Zellfraktion (SVF) aus dem Fettgewebe ist eine heterogene 
Zellpopulation die sowohl Mesenchym- als auch Endothelzellen enthält, aber keine reifen 
Adipozyten mehr. Die hier dargestellte Arbeit zeigt folgende Befunde: Ich beobachtete 
erstens, dass die Mesenchymal- und Endothelzellen der SVF ein dichtes, miteinander 
kommunizierendes Kapillar-Netzwerk in Fibrin-Hydrogelen in vitro entwickelt haben [1]. 
Zweitens konnte ich demonstrieren, dass die menschlichen engineerten Kapillaren bereits in 
vitro durch perivaskuläre Zellen (Perizyten) stabilisiert wurden. Dies wurde durch eine 
Färbung mit Perizyt-spezifischen Markern wie α-Aktin der glatten Muskeln (αSMA) oder 
Neuron-Glia-Antigen 2 (NG2) nachgewiesen.  
 Nach der Transplantation auf immuno-inkompetente Ratten schlossen sich diese 
Kapillarnetzwerke in den prä-vaskularisierten Haut-Substituten an die Ratten-Blutgefässe 
innerhalb von 3-4 Tagen an (Inoskulation). Im Gegensatz dazu war das Einwachsen von 
Ratten-Blutgefässen in die nicht prä-vaskularisierten Kontroll-Substitute verzögert. Die 
Blutperfusion der gesamten Dermis wurde in vivo erst nach dem 14. Tag beobachtet. Im 
Übrigen untersuchte ich die Effekte der schnellen Blutperfusion der prä-vaskularisierten 
Haut-Substitute auf die epidermale und dermale Hautregeneration in vivo. Die prä-
vaskularisierten Substitute zeigten in vivo eine grössere Fläche und eine verstärkte Kollagen 
Typ I-Ablagerung in der Dermis. Weiterhin analysierte ich die Expression von Homöostase- 
und Wundheilungs-Markern in der Epidermis. Die Färbung für Zytokeratine 16 und 17 ergab, 
dass die Wundheilungsperiode in den prä-vaskularisierten Haut-Substituten drastisch 
verringert war. Darüber hinaus zeigte eine verminderte Expression von Zytokeratin 19 in den 
Keratinozyten der Basalschicht, dass die Prä-Vaskularisierung ebenfalls zu einer schnelleren 
epidermalen Homöostase beitrug. 
 Im zweiten Teil meiner Arbeit habe ich verschiedene Merkmale der tissue-engineerten 
Haut-Substitute in Hinblick auf unsere zukünftige klinische Anwendung untersucht. 
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Diesbezüglich habe ich das Protokoll zur Herstellung unserer Haut-Substitute soweit 
optimiert, dass deren Produktion von 21 auf 12 Tage reduziert werden konnte [2]. Ich habe 
auch untersucht, ob es möglich ist, in unseren Haut-Substituten Pigment produzierende 
Zellen, sogenannte Melanozyten, in die Epidermis zu integrieren [3]. Ein wichtiger Teil dieser 
Studie war es die Funktion und das Verhalten der Melanozyten, sowie ihre Interaktionen mit 
den Keratinozyten in kurz- und langfristigen in vivo Versuchen, zu beobachten. Zudem 
wurden in diesen Substituten die Innervierung und das Einwachsen von Blut- und 
Lymphgefässen systematisch untersucht [4-5]. 
. 
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3. INTRODUCTION 
3.1 Human skin 
The skin is the largest organ of the body and consists of three main layers: the epidermis, 
dermis, and subcutaneous layer (hypodermis) making up 16% of body weight, with a surface 
area of 1.5 – 2 m2 [6] (Fig. 1). The most important function of the skin is to form a physical 
protection barrier against micro-organisms, ultraviolet radiation, toxic agents as well as 
mechanical insults. Moreover, skin mediates inflammatory responses and perception by 
sensory nerves. The thickness of human skin may vary between 1.5 and 4 mm depending on 
the different anatomical site, age, race and gender. Hairs, nails, sebaceous, sweat, and 
apocrine glands are regarded as skin appendages (Fig. 1).  
 
 
Figure 1. Schematic view of the composition of human skin. Human skin is composed of three layers: the 
epidermis, dermis and subcutis (hypodermis), as well as the most important skin appendages such as hairs, 
sebaceous, and sweat glands. The epidermis is a stratified squamous epithelium composed mainly of 
keratinocytes and melanocytes. The major cellular component of the dermis are fibroblasts, producing 
extracellular matrix like collagen fibers. The dermis has a rich vascular network whereas the epidermis does not 
contain any blood and lymphatic capillaries (non-vascular) [6]. 
 
3.1.1 Epidermis 
Structure and function 
A stratified squamous epidermis is the outermost surface of human skin. Its thickness varies 
between 0.05 mm on the eyelids to 0.8 ± 1.5 mm on the soles and palms. Keratinocytes are 
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the main cells of the epidermis; other cells are melanocytes, Langerhans, and Merkel cells 
(Fig. 1) [7].  
 In humans, melanocytes of the epidermis are located in the basal layer at a ratio one 
melanocyte to five keratinocytes [8]. In the hair follicle melanocytes are residing in the bulge 
and above the dermal papillae. They synthesize and transfer melanosomes containing melanin 
granules via dendritic protrusions to the keratinocytes giving color to the skin, hair, and parts 
of the eye to protect from UV irradiation [9-10]. Melanocytes are derived from precursor cells 
called melanoblasts that originate from the neural crest. Both light- and dark-skinned people 
have the same number of melanocytes, however they differ in the amount, type, and 
distribution of melanin that each melanocyte produces [11]. Melanin pigment occurs in two 
types: black to brown eumelanin and yellow to reddish pheomelanin [11]. High eumelanin 
content is found in dark-skinned people, who are better protected from UV radiation. In 
contrast, in albinos melanin synthesis is impaired and they often have very low or no pigment 
in their skin, hairs, and eyes. 
 Langerhans cells are dendritic cells distributed in all suprabasal layers of the 
epidermis, mostly in the spinous layer [12]. They can be identified by the expression of a 
specific protein, named CD1a and make up 2-8% of all epidermal cells. Langerhans cells 
protect skin from infections by the recognition, uptake, processing, and presentation of 
antigens to T lymphocytes [7]. 
 Merkel cells were first described by Friedrich S. Merkel in 1875 as touch cells with a 
sensory touch function. They can be specifically identified by the expression of cytokeratin 
20. In humans, Merkel cells are scattered along the dermo-epidermal junction, in eccrine 
glandular ridges of glabrous skin, within the hair follicles of hairy skin, and in certain 
mucosal tissues. As skin sensory receptors, Merkel cells stay in close contact with dermal 
sensory nerve endings. They may contribute to the development of the nerve plexus in the 
upper dermis, ecrine sweat glands, the hair follicle, and nails [7, 13]. 
 Keratinocytes form four separate layers which can be distinguished by the different 
stages of keratin maturation: 
– stratum basale (basal or germinativum cell layer) 
– stratum spinosum (spinous or prickle cell layer) 
– stratum granulosum (granular cell layer) 
– stratum corneum (horny layer) 
   INTRODUCTION 
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In addition, the stratum lucidum represents a thin layer of translucent cells present at the 
border between the stratum granulosum and stratum corneum. The stratum lucidum is mostly 
seen at body sites covered by a relatively thick epidermis. 
 Epidermal stratification is characterized by the graded distribution of specific 
cytoskeletal and junction components, including specific keratins (Ks), desmogleins (DSGs), 
and cadherins as demonstrated in Fig. 2 (right part).  
 
 
Figure 2. Schematic view of human interfollicullar epidermis. The epidermis is composed of stratified cell 
layers, which differentiate to allow a constant renewal of the skin. A hematoxylin- and eosin-staining (left, 
above) and an accompanying scheme (middle) illustrate four main skin layers: stratum basale, stratum spinosum, 
stratum granulosum, and stratum corneum. Epidermal stratification is characterized by the graded distribution of 
specific cytoskeletal and junction components, including specific keratins (Ks), desmogleins (DSGs), and 
cadherins. Abbreviations: DP, desmoplakin; DSC, desmocollin; E-cadherin, epithelial cadherin; P-cadherin, 
placental cadherin; PG, plakoglobin; PKP1, plakophilin 1 [14].  
 
Organization of the stratified epidermis  
Keratinocytes within the epidermis show apical-basal axis of polarity. In the basal layer 
keratinocytes are anchored to the basement membrane by integrins (Fig. 2). These 
heterodimeric transmembrane receptors consist of α- and β-subunits and bind specific 
extracellular matrix (ECM) components via their extracellular domains [15]. Integrin α6β4 
has a crucial role in the formation of the hemidesmosome complex that contributes to the 
anchoring of basal keratinocytes to the underlying basement membrane (Fig. 3). An inherited 
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defect in this anchorage leads to epidermolysis bullosa (EB), a severe skin disorder causing 
skin blisters and fragility. 
 As a very dynamic organ, skin possesses a high regenerative potential and is in a 
constant state of change [16]. One epidermal keratinocyte stem cell may be able to give rise to 
enough cells to cover the body surface [17-18]. Keratinocyte stem cells reside in the basal 
layer of the epidermis and divide to give rise to transient amplifying cells, which can further 
divide or exit the cell cycle to differentiate [19]. Once keratinocytes start to differentiate, they 
detach from the basement membrane by losing their hemidesmosome anchorage and move 
upwards in the epidermis. First they enter the spinous cell layer, then move into the granular 
layer, and eventually enter the outer cornified layer of the epidermis. Whereas basal, spinous 
and granular cells are alive, the terminally differentiated cells of the stratum corneum are dead 
and constitute the outer protective cell layer. 
 Epidermal keratinocytes are linked through protein bridges called desmosomes or 
macula adherens (Latin for adhering spot), which provide strong mechanical cell-cell 
cohesion [20] (Fig. 3). Desmosomes from neighboring cells are connected by members of the 
cadherin family, called desmogleins and desmocollins, situated between two cells. On the 
cytoplasmic side of each cell membrane these cadherin-type proteins inset into a dense 
complex of anchoring proteins (plakophilin, plakoglobin, and desmoplakin) via armadillo 
proteins [14]. Desmosomes bind to intracellular keratin cytoskeletal filaments (tonofilaments) 
providing a strong cell-cell junction [21]. The disruption of this desmosome-keratin filament 
complex leads to a breakdown of cell adhesion causing the symptoms of the blistering skin 
disease (Pemphigus vulgaris and foliaceus). The patients suffering from this disease produce 
auto-antibodies directed against desmoglein 3 and desmoglein 1 [22]. 
 Adherens junctions are a second family of cadherin-based junctions in the epidermis. 
They are composed of the classic cadherins - E-cadherin (epithelial) and P-cadherin (also 
known as cadherin 3) forming an adhesion between the neighboring cells through homophilic, 
calcium-dependent interactions (Fig. 3). An ablation of both cadherins causes lethal blistering 
[23]. The cytoplasmic domains of these cadherins are associated with important signaling 
proteins such as p120 catenin and β-catenin. β-catenin binds via armadillo repeat domains to 
α-catenin, an actin-binding protein [14]. 
 Tight junctions appear at the apical side of keratinocytes in the stratum granulosum 
preventing fluid loss and protecting against pathogens (Fig. 3) [21, 24]. Tight junctions are 
composed of transmembrane proteins (claudins and occludins) linked to the actin 
cytoskeleton [25]. Other interaction partners of claudins are: the zona occludens (ZO) proteins 
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ZO-1, ZO-2, ZO-3, and multi-PDZ domain protein-1 [26]. Tight junctions, adherens 
junctions, and desmosomes constitute the intercellular junctional complex in mammals (Fig. 
3). 
 
 
Figure 3. Organization of the junctional complex of epithelial cells. Tight junctions are present in the later 
spinous layers of the epidermis at the most apical position and maintain the epithelial barrier function beneath 
the stratum corneum. Adherens junctions organize cortical actin, and together with desmosomes attach epithelial 
cells together. Tight junctions, adherens junctions, and desmosomes form the “junctional complex”. Gap 
junctions form patch-like lateral connections between the cells and form channels for the transport of small 
molecules between neighboring cells. Hemidesmosomes are integrins which anchor the cells to the basal lamina. 
In the light microscopy picture keratin tonofilaments of epithelial cells (in red) are associated with desmosomes, 
which are shown by a desmoplakin staining (in green). At the ultrastructural level desmosomes appear as 
bilaterally symmetrical structures with a zipper-like midline as a central core region that spans the intercellular 
space between opposing cells [21]. 
 
Cytoskeletal proteins  
 There are three main classes of filaments in eukaryotic cells: microtubules, actin filaments 
(microfilaments or F-actin), and intermediate filaments (Fig. 4) [27]. Microtubules have a 
diameter of 20-25 nm and consist of two different globular protein subunits such as alpha-
tubulin and beta-tubulin, which form together long, hollow cylinders. Actin filaments are 
helical polymers formed by globular actin monomers, called G-actin. They are the smallest 
components of the cytoskeleton with a diameter of about 7-9 nm. Intermediate filaments are 
of about 8-12 nm in diameter and provide strong mechanical stability to the cell.  
 Keratins (previously also called cytokeratins) are filament-forming proteins 
(tonofilants) of epithelial cells and are essential for normal structure and function of the 
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epidermis [27]. Accordingly to their biochemical properties, keratins are classified into two 
groups: type I or acidic and type II or basic epithelial keratins [28]. 
There are also other types of intermediate filaments such as type III: desmin, 
vimentin, glial fibrillary acidic protein (GFAP), type IV: nestin, and type V: lamin A. 
 
 
Figure 4. Structural organization of microtubules, microfilaments, and intermediate filaments in a cell [29]. 
 
3.1.2 Dermis 
The dermis contains nerve endings, blood and lymphatic vessels, as well as skin appendages 
such as hair follicles, sweat, and sebaceous glands often reaching into the hypodermis [30]. 
The dermis comprises two layers, a thin papillary and thicker reticular layer. The upper 
papillary dermis gives shape to the stratum basale of the epidermis through finger-like 
protrusions called dermal papillae (Fig. 5). The papillary layer contains loosely arranged 
collagen fibres, whereas in the deeper reticular layer bundles of collagen are thicker and 
appear as reticulated (net-like) structures (Fig. 5). 
The dermis is populated by fibroblasts which deposit collagen, elastin fibers, and 
structural glycosaminoglycans [7]. Collagen fibers make up 75% of the dermis providing 
mainly structural and mechanical strength to the skin. The most abundant type of collagen in 
this layer is type I (89-90%) and type III (8-12%) collagen. Elastin maintains normal skin 
elasticity and flexibility, whereas glycosaminoglycans keep the optimal level of hydration. 
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Figure 5. Hematoxylin- and eosin staining of normal human skin showing the two components of the dermis - 
the papillary and the reticular layer. The dermal papillae protruding into the epidermis belong to the papillary 
layer, characterized by a fine network of collagen fibrils. In contrast, the underlying reticular layer appears 
reticulated (net-like) due to a dense and tight collagen bundle meshwork. Rete subpappillare separate these two 
layers [30].   
 
Basement membrane (BM) 
The epidermis is separated from the underlying dermis by the complex basement membrane 
(BM), deposited by both keratinocytes and fibroblasts [31-32]. Fibroblasts deposit laminin-1, 
nidogen-1/2, collagen type IV and VII, whereas keratinocytes produce laminin-332 (laminin-
5), perlecan, and also collagen IV and VII [32-34].  
 The BM is composed of a set of distinct glycoproteins and proteoglycans to form 
anchoring complexes and provide an adhesive and dynamic interface (Fig. 6) [31, 35-36]. 
These complexes are composed of the hemidesmosomes, anchoring filaments, and anchoring 
fibrils. Anchoring filaments extend from the basal cell membrane into the lamina lucida, 
connecting hemidesmosomes with the lamina densa, containing collagen type IV fibrils 
coated with perlecan. The lamina lucida with the lamina densa make up the basal lamina. 
Further, the anchoring complex - BP180, plectin, laminin - interacts with transmembrane 
alpha6beta4 (α6β4) integrin. During BM assembly α6β4 becomes integrated into 
hemidesmosome complexes and connected to the keratin network via the β4 subunit. 
Moreover, α6β4 binds to laminin-332 (laminin-5) [37]. 
 Anchoring fibrils, formed by collagen type VII, extend from the lamina densa into the 
papillary dermis and connect the lamina densa to interstitial collagen fibrils. Thus, the BM 
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connects the complex basal keratinocyte cytoskeletal framework with the abundant network 
of interstitial collagen bundles in the dermis. 
 
 
Figure 6. Ultrastructural characterization of the basement membrane (BM) of skin. (a) The anchoring complexes 
between epidermis (E) and dermis (D) form the dermo-epidermal junction. (b) The collagen-epidermal interface 
of a 3D co-culture of keratinocytes with fibroblasts similar to normal skin. (c) Immuno-electron microscopy 
indicating the alignment of collagen IV with the lamina densa (LD) and (d) colocalization of integrin α6β4 with 
laminin-332 (laminin-5; Lm5) (small/large gold particles staining). (e) Schematic representation of the BM. The 
mat-like BM structure develops through the interactions between the four major BM components. Abbreviations: 
CIV, collagen IV; LD, lamina densa; HD, hemidesmosomes [31].  
 
Blood and lymphatic vessels 
The dermis is rich in blood vessels. They provide nutrients to the skin and regulate body 
temperature. The dermal vasculature consists of both a superficial and a deep plexus of 
arterioles and venules being connected by communicating vessels that arise from arteries and 
lead eventually to veins that reside within septa of the subcutaneous fat (Fig. 7) [7]. The 
superficial plexus also called the “subpapillary plexus” is formed just beneath the epidermis 
and consists of  finger-like capillary loops projecting into the dermal papillae, whereas the 
deep plexus is positioned in the lower part of the reticular dermis (Fig. 7) [38]. Both plexuses 
are connected by communicating blood vessels that are oriented perpendicular to those 
plexuses. From the superficial plexus, a branch of capillaries loops into each dermal papilla 
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with a single loop of capillary vessels, one arterial and one venous. Dilatation or constriction 
of these capillary loops plays a direct role in the thermoregulation of skin.  
 The lymphatic system of skin develops through lymphangiogenesis in parallel with 
the blood vascular system. Interestingly, lymphatic vessels are normally absent in avascular 
structures such as epidermis, hair, nails, cartilage, cornea, and in some organs such as brain 
and retina. Abundant lymphatic networks in the dermis form superficial and deep plexuses 
corresponding to those of the blood vascular system. The main function of the skin lymphatic 
system is to collect the lymph and drain it into regional lymph nodes. 
 
 
Figure 7. The dermal vasculature consists of a network of two plexuses that parallel the skin surface. The 
superficial plexus (subpapillary plexus) is situated in the upper part of the dermis, whereas the deep plexus is 
positioned in the lower part of the reticular dermis. Both plexuses are connected by communicating blood vessels 
that are oriented perpendicular to those plexuses. Capillaries emanate from the vascular plexuses to supply the 
papillary-periadnexal (adventitial) dermis and the epithelial and non-epithelial structures of adnexa housed in the 
reticular dermis [38]. 
 
The process of new blood and lymphatic vessel formation in skin transplants, especially in 
human tissue-engineered skin substitutes, remains poorly understood. I have therefore 
investigated the kinetics of host vessel ingrowth within those skin substitutes [4].  
 The adequate and rapid revascularization of skin transplants is crucial for the initial 
take, survival, and incorporation into the recipient’s tissue. Studies on full-thickness skin, 
containing blood vessels and capillaries, demonstrated the fusion of host and graft capillaries 
(inosculation) three days after transplantation [39-40]. These studies used either intravenous 
injection with radioisotopes [39] or India ink [40], and the reestablishment of blood flow in 
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transplant vessels was observed at two or four days, respectively. Finally, the group of Zarem 
et al. established a modified transparent skin chamber in the mouse and demonstrated that 
revascularization of full-thickness skin grafts occurs through both vascular ingrowth from the 
recipient wound site and inosculation [41]. Furthermore, skin graft revascularization also 
involves vascular regression and replacement of graft endothelial cells through angiogenesis 
and reconnection (inosculation) [42].  
 As far as lymphatic regeneration after skin transplantation is concerned, very few 
studies have been performed. A study of Yan et al. in mouse suggested that lymphatic 
regeneration after skin tissue transfer starts at the peripheral edges of the graft and occurs by 
ingrowth of lymphatic vessels and spontaneous re-connection with the existing lymphatics 
[43]. However, the ingrowth of blood vessels into skin wounds precedes formation of new 
lymphatic vessels [44]. Nogami et al. followed the recovery of lymphatic vessels in rat skin 
incision wounds up to 12 weeks and found that lymphatic vessels were not present in the 
wound area, but only in the surrounding intact tissue [45]. This impairment of lymphatic 
regeneration is linked to lymphedema, fibrosis, and scar formation [46-47].  
 
Innervation and nerve endings of the skin 
As skin is an important sensory organ, it has a rich nerve supply containing nerve endings of 
different types (Fig. 8).  
The skin’s afferent nervous system consists of both myelinated and non-myelinated 
fibres, which transmit impulses from the various nerve endings, and are therefore responsible 
for cutaneous sensation. The skin sensory nerve endings consist not only of free nerve 
endings, but can also appear as specialized “encapsulated” nerve endings such as Meissner’s, 
Pacinian, and Ruffini’s corpuscles [48]. 
The skin’s efferent nervous system comprises non-myelinated fibres from the 
sympathetic nervous system, which are in contact with blood vessels and the skin appendages, 
for example with arrector pili muscles and eccrine sweat glands. 
After severe skin injuries such as third-degree burns, there is no sensation in the 
burned area as all nerve endings are destroyed. The grafted skin will have little or no 
sensation directly after transplantation, but will slowly regain it by the regeneration of nerve 
endings. However, the mechanism of reinnervation is still poorly understood. Interestingly, 
nerves are often aligned with blood vessels and show similar patterns in the development and 
regeneration after injuries [49-54]. 
   INTRODUCTION 
 
 15 
 
Figure 8. The  innervation of skin. Green fibers stained for pan-neuronal protein PGP9.5 show the typical 
innervation of the fingertip skin. Blood capillaries are stained using an antibody to collagen type IV (red), and 
the epidermis with ulex (blue). Two encapsulated Meissner's corpuscles can be observed near to the dermo-
epidermal junction. Abbreviations: ENF, epidermal nerve fibers; D/E J, dermal-epidermal junction; Epid, 
epidermis; Cap, capillaries; MC, Meissner's corpuscles. Image courtesy of Dr. Patrick Dougherty at M. D. 
Anderson Cancer Center, Houston. 
 
 It has been postulated that blood vessels serve as guiding instances for nerve 
outgrowth by the secretion of specific factors. Several molecules with attractive and repulsive 
properties have been identified regulating the proper path finding and guidance of nerves. 
These include the netrins, the semaphorins, the slits, and their receptors. Moreover, other 
factors including a glial-derived neurotrophic factor (GDNF) family member called artemin, 
and others such as endothelin-3, have been described [55-56]. These factors are released by 
smooth muscle cells surrounding arteries. They direct the growth of sympathetic nerves along 
these vessels to the end organs [57]. Vascular endothelial growth factor (VEGF-A) also 
controls axon cone growth and sprouting along arterial networks [58-59]. 
 
3.1.3 Hypodermis 
The hypodermis (also called subcutis or the subcutaneous fat layer or superficial fascia) is a 
layer between the dermis and the underlying fascia of muscles [7]. It is, like the dermis, 
derived embryologically from mesenchyme and consists of well-vascularized, loose, areolar 
connective tissue and adipose tissue. The main function of it is fat storage as well as 
insulation and cushioning of the integument. Fat-storing cells, called adipocytes, synthesize 
and store lipids in their cytoplasm, thereby appearing as large clear cells with the nucleus 
close to the plasma membrane at its border or not visible at all (Fig. 9A). Adipose tissue is 
highly vascularized with each adipocyte being in contact with at least one capillary (Fig. 9B). 
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This rich blood supply provides sufficient support for the active metabolism, which occurs in 
the thin rim of cytoplasm surrounding the lipid droplet. 
 
Figure 9. Adipose tissue. A. Hematoxylin- and eosin staining showing lipid drops in adipocytes, nuclei and 
blood capillaries (magnification 100x). B. Specific staining for adipocytes (in red), which are encircled by blood 
capillaries stained in green (magnification 160x). Image courtesy of David Burk, Pennington Biomedical 
Research Center 
 
Cell isolation from adipose tissue is performed under local anesthesia using simple 
procedures such as liposuction. The so-called stromal-vascular fraction (SVF) can be isolated 
in large quantities and represents an attractive cell source for regenerative medicine [60-61].   
I routinely isolated 1.6 – 0.9 x 105 nucleated cells from 1 ml of a fat liposuction biopsy and    
1 – 0.55 x 105 nucleated cells from 1 gram of an excision biopsy [62]. Figure 10 illustrates the 
different steps of the isolation and distinct applications of adipose-derived stem cell. For this 
procedure the liposuctioned fat is washed and treated with collagenase II to release single 
cells from the fat tissue. 
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Figure 10. Scheme of human adipose-derived stem cell (ASC) isolation and differentiation for potential clinical 
applications. Abbreviations: SVF, stromal vascular cell fraction [61]. 
 
After enzyme inactivation, the so called SVF is pelleted after centrifugation. The SVF is a 
heterogeneous cell population composed of mature cells such as endothelial cells, adipose 
stromal cells (ASC), as well as distinct progenitor/stem cell populations [61] (Fig. 11).  
Upon expansion in monolayer cultures on tissue culture plastic, the SVF yields an 
adherent stromal cell population, termed adipose stromal cells (ASC) [63-64]. ASC are 
characterized by the expression of typical mesenchymal/stromal markers such as CD90 and 
CD73 and completely lack other cell types [64]. ASC demonstrate a higher proliferation 
potential and higher number of stem cells in comparison to bone marrow stem cells (BMSC) 
and obtaining them is less invasive as compared to bone marrow isolation. ASC have 
potential therapeutic implications for clinical practice as they can be easily induced to the 
osteogenic, chondrogenic, and adipogenic lineage in vitro, and injected back to the patient’s 
damaged organ (Fig. 10). 
 Due to the shortage of autologous skin cells in severely burned patients, other non-
skin cell sources such as adipose-derived cells have been explored for skin tissue engineering. 
I characterized the cells of the human SVF and succeeded in using them to reconstruct the 
prevascularized dermal compartment of a full-thickness skin substitute. I demonstrated that 
endothelial and stromal cells both derived from the SVF, assemble into mature vascular 
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structures in vitro, thus actively contributing to the prevascularization of tissue-engineered 
skin grafts and stimulating their engraftment in vivo [1]. 
 
 
Figure 11. Cellular composition of the stromal vascular fraction (SVF) of adipose tissue. SVF isolated from an 
excised or lipoaspirate fat biopsy comprises distinct mature, progenitor, and stem cell types. Depending on the 
donor differences and adipose tissue processing method, the cell composition of the SVF can vary significantly 
(modified from “Breaking down fat: Composition of stromal vascular fraction”, A. Bersenev, 2013). 
 
3.2 Skin injuries and wound healing 
 
3.2.1 Skin injuries 
Thermal injuries, such as scalds and burns, are one of the most devastating conditions 
encountered in medicine. A burn is primarily caused by heat or due to radiation, radioactivity, 
electricity, friction or contact with chemicals. WHO estimated that 322.000 deaths every year 
are caused worldwide by fire burns only - the vast majority occur in low- and middle- income 
countries [65-66]. These severe injuries impair all aspects of the patient’s life, from the 
physical to the psychological and pose difficult and unique medical challenges. Tragically, 
children under 5 years and the elderly (aged over 70 years) have the highest fire-related burn 
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mortality rates worldwide. In addition to those who die, millions are left with lifelong 
disabilities and scars. 
 
3.2.2 Wound healing 
Immediately after an injury, a synchronized wound healing process with multiple biological 
pathways becomes activated [67] (Fig. 12).  
 
 
 
 
 
 
 
Figure 12. Schematic representation of the three wound healing stages. a) During the first phase - inflammation - 
a fibrin clot is formed and neutrophils are recruited to the wound to remove bacteria and damaged tissue. b) 
During proliferation phase an eschar is formed and cells such as keratinocytes and fibroblasts migrate into the 
wound to close the wound and form granulation tissue, respectively. c) During the third phase, tissue maturation 
and remodeling occurs. Parallel collagen fibers (violet) are deposited by fibroblasts and a scar tissue is formed 
[67]. 
 
The normal healing process following an injury of the skin starts when platelets form 
a fibrin clot to stop bleeding. Subsequently, neutrophils enter the wound site and begin the 
removal of bacteria and damaged tissue during the inflammatory phase. This triggers 
migration of other cells such as fibroblasts to the wound site and as a result a simple 
C 
B A 
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granulation tissue is formed. The subsequent proliferative phase is characterized by extensive 
growth of epithelial cells, fibroblast deposition of collagen fibers in a disorganized pattern, 
and ingrowth of blood vessels. Finally, during the maturation/remodeling phase, these 
collagen fibers become more organized, the number of blood vessels is normalized, and the 
epidermis is restored to normal thickness. The newly developed tissue fills the area of injury, 
however, forming a fibrotic tissue called scar. 
 Wound healing is substantially delayed in patients suffering from diabetes or after 
radiation exposure. By contrast, an excessive wound response may lead to hypertrophic scars 
and keloids characterized by the deposition of large amounts of extracellular matrix, impaired 
vascularization, and cell proliferation. These frequently occur after major skin injuries such as 
burns [67]. 
 
3.3 Skin replacement therapies   
The loss of skin occurs very often due to burns, trauma, congenital abnormalities, disease, or 
chronic, non-healing ulcers in elderly people [68-69] (Fig. 13). These skin defects can lead to 
skin necrosis and thus represent a challenging problem for public health [70-71]. Hence, the 
main aims of burn care are to restore skin, its function, and appearance. 
 Skin wounds measuring more than 4 cm
 
in diameter will not heal spontaneously and 
need to be closed by skin graft transplantation [72]. After the early debridement of the 
damaged tissue, an autologous split-thickness skin graft harvested from an uninjured skin site 
is transplanted to cover the skin defect [71] [73]. This treatment method is used as the today’s 
“gold standard”, however it usually leads to disfiguring hypertrophic or keloid scars if 
transplanted without any dermal matrix [74-75].  
In comparison, autologous full-thickness skin transplantation can be performed only 
for patients with skin injuries smaller than 1-2% of the Total Body Surface Area (TBSA) [68]. 
The major problem is the lack of a functional dermis, especially in large skin wounds over 
70% of the TBSA with only 30% of remaining normal skin which is insufficient for 
harvesting [76]. Hence, its frequent wide use is limited by donor site availability.  
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Figure 13. The need of tissue-engineered skin. Left: Acute wounded patient suffering from a large burn after 
escharatomy. Because of the large Total Body Surface Area (TBSA) affected, not enough healthy skin is 
available for a split-thickness skin graft. Right: The elective situation. Patient suffering from a giant congenital 
melanocytic nevus in the elbow area. After resection, the best medical treatment would be the application of a 
tissue-engineered skin substitute to match skin color and texture as closely as possible [68]. 
 
3.3.1 Tissue engineering of skin 
Tissue engineering of skin substitutes in the laboratory represents an advanced therapy for 
acute and chronic skin wounds. In the past, autologous cultured epidermal autografts (CEA) 
were used for burn and reconstructive surgery, however this mostly did not result in a 
satisfactory and esthetic skin replacement [77-78]. Therefore, the ultimate goal of the Tissue 
Biology Research Unit (TBRU) was to tissue engineer a novel human dermo-epidermal full 
thickness skin substitute for clinical use. Using this approach only a small patient’ biopsy is 
harvested, and after subsequent cell isolation and expansion in vitro, autologous skin 
substitutes are produced. They show many features of an “ideal” skin regarding the anatomy, 
physiology, biological stability, and cosmetic properties [2, 79-80]. The dermal compartment 
is reconstructed using a collagen type I hydrogel containing autologous fibroblasts and with 
autologous keratinocytes on the top of it to form the epidermal coverage [79] (Fig. 11). These 
substitutes represent an optimal skin replacement for deep wounds as they provide both skin 
layers as for long-term wound coverage with reduced or no scarring. 
 To further improve the skin grafts properties, and to achieve skin pigmentation for 
sufficient protection against UV-radiation, we developed tissue engineered autologous dermo-
epidermal substitutes with integrated melanocytes. Our in vivo pre-clinical studies 
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demonstrated that we were able to reconstruct the patient’s own skin color [68]. This 
technique also holds a great promise to treat hypo- or hyperpigmentation skin disorders such 
as melanocytic nevus and vitiligo [81].  
 However, successful transplantation of tissue engineered skin substitutes thicker than 
400μm depends on the rapid onset of blood perfusion. This ensures adequate supply of 
oxygen and nutrients, cell survival, and function of the transplanted skin grafts [82-84]. 
Whereas autologous full-thickness skin grafts become perfused within days by inosculation of 
its pre-existing blood vessels with those of the patient, avascular skin substitutes are totally 
dependant on neovascularization from the wound bed. This process can take up to 14 days or 
even longer in patients with compromised angiogenesis (e.g., diabetes or the aged) [85]. 
Therefore, the incorporation of microvascular networks into the tissue-engineered skin graft 
before its transplantation, hence pre-vascularization, considerably accelerates its blood 
perfusion, integration, and remodeling of the transplant. 
 We succeeded in developing a plexus of highly organotypic, branching, lumen-
forming capillaries in engineered skin substitutes. After transplantation onto immuno-
incompetent rats, human capillaries rapidly connected to the vasculature of the recipient’s 
animal [1, 86-87]. 
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4. RESULTS 
4.1 Tissue-engineered dermo-epidermal skin grafts prevascularized with 
adipose-derived cells 
 
Agnieszka S. Klar
1
, Sinan Güven
2
, Thomas Biedermann
1
, Joachim Luginbühl
1
, Sophie 
Böttcher-Haberzeth
1
, Claudia Meuli-Simmen
4
, Martin Meuli
3
, Ivan Martin
2
, Arnaud 
Scherberich
2*
, and Ernst Reichmann
1* 
 
1Tissue Biology Research Unit, Department of Surgery, University Children’s Hospital 
Zurich, Zurich, Switzerland. 
2
Department of Biomedicine, University Hospital of Basel, University of Basel, Basel, 
Switzerland. 
3
Department of Surgery, University Children’s Hospital Zurich, Zurich, Switzerland. 
4
Department of Plastic, Reconstructive, Esthetical and Hand Surgery, Kantonsspital Aarau, 
Aarau, Switzerland. 
 
*
Corresponding authors: Prof. Dr. Ernst Reichmann, Tissue Biology Research Unit, August 
Forel Str. 7, CH-8008 Zurich, Switzerland, Email: Ernst.Reichmann@kispi.uzh.ch; 
PD. Dr. Arnaud Scherberich, Department of Biomedicine, University Hospital of Basel, 
University of Basel, Basel, Switzerland, Email: Arnaud.Scherberich@usb.ch 
 
 
 
Published in:  
Biomaterials, 2014, 35(19):5065-5078 
Impact factor 8.3 
 
 
RESULTS – PUBLICATION I 
 
24  
Abstract 
 
The major problem in skin grafting is that tissue-engineered skin grafts after their 
transplantation are initially entirely dependent on diffusion. Since this process is slow and 
inefficient, nutrients, growth factors, and oxygen will insufficiently be supplied and the 
regenerating graft will undergo a physiological crisis, resulting in scar-like dermal structures 
and shrinkage. The tissue-engineering of a vascular network in human dermo-epidermal skin 
substitutes (DESS) is a promising approach to overcome this limitation. Here we report, for 
the first time, on the use of the adipose stromal vascular fraction (SVF)-derived endothelial 
cell population to tissue-engineer DESS containing a highly efficient capillary plexus. To 
develop vascular networks in vitro, we employed optimized 3D fibrin or collagen type I 
hydrogel systems. Upon transplantation onto immune-deficient rats, these preformed vascular 
networks anastomosed to the recipient’s vasculature within only four days. As a consequence, 
the neo-epidermis efficiently established tissue homeostasis, the dermis underwent almost no 
contraction, and showed sustained epidermal coverage in vivo. Overall, the here described 
rapid and efficient perfusion of SVF-based skin grafts opens new perspectives for the 
treatment of hitherto unmet clinical needs in burn/plastic surgery and dermatology.  
 
Keywords 
Fibrin; Collagen; Skin tissue-engineering; Angiogenesis; Adipose tissue; Endothelial cell 
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Introduction 
 
Skin defects caused by burns, trauma, or non-healing chronic wounds are frequent and often 
cause severe clinical problems [1]. Recently, a tissue-engineered dermo-epidermal full-
thickness skin substitute (DESS) [2-6] has been proposed as an alternative to autologous split-
thickness skin grafting, which represents the current clinical gold-standard, yet is limited by 
donor-site shortage, propensity to contraction, shrinkage and scarring [7-8]. Despite its 
innovative clinical potential, the major challenge associated with the above mentioned DESS 
might be insufficient initial vascularization, resulting in some kind of nutritional crisis early 
after transplantation, and impaired regeneration due to the initial lack of oxygen and nutrients. 
Notably, this crisis can not be avoided by any kind of the presently used skin grafts with the 
exception of full-thickness skin. This graft is prevascularized and gets rapidly perfused (by 
inosculation) after transplantation. However, full-thickness skin grafts can only be used to 
cover relatively small surfaces, due to the severe trauma that goes along with its preparation.  
  Numerous strategies to enhance vascularization of autologous grafts were suggested 
[9-11]. A promising approach is the generation of prevascularized grafts harboring a vascular 
network, able to rapidly anastomose with the blood vessels of the host site upon 
transplantation, thereby promoting cell survival, differentiation, and physiological integration 
of the engineered tissue [12-14]. Such a self-assembly of organotypic capillary networks can 
be achieved in vitro by co-culture of primary endothelial cells (EC) and stromal cells (e.g. 
mesenchymal stem cells, dermal fibroblasts) in three-dimensional (3D) cultures. Certain 
stromal cells may differentiate into perivascular cells (pericytes), which are involved in the 
development and remodelling of blood capillaries by stabilizing and guiding EC and by 
releasing pro-angiogenic growth factors, such as angiopoietin, FGF, VEGF, and TGF [15-16]. 
Several attempts aimed to develop a vascularized dermal equivalent by using human dermal 
fibroblasts (HDF) and EC, such as human dermal microvascular endothelial cells (HDMEC) 
[17-18], human umbilical vein endothelial cells (HUVEC) [19-21], or human blood 
outgrowth endothelial cells (HBOEC) [22]. However, many of these approaches are based on 
dermal stromal and other vasculogenic cells which are difficult to obtain in sufficient 
numbers. Therefore, their clinical application is difficult to envision. 
The disadvantage of using autologous dermal fibroblasts in combination with 
HDMEC is their cumbersome and time-consuming isolation and culture procedure. Other EC, 
like HUVEC and HBOEC are derived from sources such as umbilical cord and cord blood, 
which are both allogeneic to the patient and potentially immune-reactive. Application of 
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peripheral blood-derived HBOEC is limited due to their low precursor frequency, long in 
vitro cell differentiation, and prolonged expansion time. Furthermore, the in vivo vasculogenic 
capacity of HBOEC declines rapidly with time in cell culture [23]. Other investigators using 
HUVEC reported their impaired survival and in vivo skin engraftment unless the cells were 
transduced with an anti-apoptotic Bcl-2 gene [24]. 
The ideal clinical approach to create a prevascularized dermal equivalent should use 
abundant autologous cells, derived from a single-cell source, and easy harvested from the 
patient with minimal donor-site morbidity. Therefore, the stromal vascular fraction (SVF) of 
human adipose tissue is a promising option since it perfectly corresponds to the above-
mentioned profile [25]. The SVF is known as a heterogeneous population of multipotent stem 
and progenitor cells, including EC, stromal cells, pericytes, preadipocytes, as well as 
hematopoietic cells [26-30]. 
The advantages of the SVF are the following: First, one-single SVF biopsy delivers 
autologous stromal, vasculogenic and pericytic cells in an ideal ratio. Second, unlike other 
cell types, such as skin-derived fibroblasts and EC, SVF cells reveal a high vasculogenic 
potential across all age groups, even in elderly patients or with burns [31-32]. Third, cells of 
the SVF can be isolated in a fully automated procedure [33], in large quantities so that they do 
not require in vitro expansion, and can be used freshly, e.g. for direct intraoperative use [34]. 
SVF-seeded constructs have been shown to improve heart function and sustain microvascular 
perfusion and function in the infarct area [35-36]. Moreover, it has been demonstrated that if 
cultured within 3D scaffolds, the combination of endothelial and stromal cells both derived 
from the SVF assemble into vascular structures, thus actively contributing to the 
vascularization of tissue-engineered bone grafts, and stimulating their engraftment in vivo 
[37-38]. 
Upon expansion in standard monolayer cultures on tissue culture plastic, the SVF 
yields a homogeneous, plastic-adherent stromal cell population expressing typical 
mesenchymal/stromal markers, termed adipose stromal cells (ASC) [39-40]. Lu et al. 
provided direct evidence that the combination of two mesenchymal cell populations, namely 
ASC and dermal fibroblast can significantly improve epidermal morphogenesis in vitro [41]. 
ASC combined with an acellular dermal matrix (ADM) were also successfully used to 
accelerate wound healing of full-thickness cutaneous wounds in a murine model. In this 
model ASC promoted retention and neovascularization of the scaffold [42]. 
In the present study, we aimed at using the SVF to generate skin grafts containing 
their own intrinsic microvascular plexus as a nutritional support for both, the dermal and the 
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epidermal compartment. We found that SVF cells developing into a functional capillary 
plexus prior to transplantation markedly enhanced graft take and remodeling upon rapid graft 
perfusion four days after transplantation, thereby supporting survival, and triggering 
functionality of the transplanted graft. 
 
Materials and Methods 
 
Cell isolation and culture 
Human subcutaneous adipose tissue samples were obtained either from lipoaspirates or fat 
excisions from healthy human donors (between 18 and 68 years of age), female or male, 
mostly from abdominal body location, all of them undergoing a surgical fat liposuction or 
excision operation. All donors gave their informed consent and the study protocol was 
approved by the local ethical committee (EKBB, Ref. 78/07). Lipoaspirates or excised fat 
samples were minced into small pieces and digested with 0.075% (W/V) type II collagenase 
(355 U/mg, Worthington, Lakewood, NJ, USA) for 60 min at 37°C under shaking. After 
centrifugation at 200 g for 10 min, the oil and aqueous layers were discarded. The resulting 
pellet was washed in phosphate buffered solution (PBS, Gibco, Invitrogen, Carlsbad, CA, 
USA) and passed through a 100 µm and 40 µm strainer. Red blood cells were lyzed by 
incubation for 2 min with a buffer containing 0.15 M/l ammonium chloride, 1.0 mM/l 
potassium bicarbonate (both Merck, Darmstadt, Germany), and 0.1 mM/l Na-EDTA (Fluka 
Analytical, Sigma-Aldrich Chemie GmbH, Buchs, Switzerland). After centrifugation and 
washing in PBS, the SVF cell pellet was resuspended in a complete medium (CM) consisting 
of α-Modified Eagle’s Medium (α-MEM, Gibco) supplemented with 10% fetal bovine serum 
(FBS), 1% hepes, 1% sodium pyruvate and 1% penicillin-streptomycin-glutamin (100x) 
solution (all from Gibco), stained with crystal violet (Sigma) and counted by using a 
Neubauer chamber. We routinely isolated 1.6 – 0.9x105 nucleated cells from 1 ml of a fat 
liposuction biopsy and 1 – 0.55x105 nucleated cells from 1 gram of an excision biopsy [33]. 
 For monolayer expansion, SVF cells were seeded at a density of 2×10
3
 cells/cm
2
 onto 
tissue culture plates, cultured in CM supplemented additionally with 5 ng/ml FGF-2 (R&D 
Systems) and passaged at a density of 3×10
3
 cells/cm
2
 when confluent. The donor-matched, 
monolayer-expanded adipose-derived cells will be thereafter referred to as adipose stromal 
cells (ASC), to distinguish them from the population of freshly isolated SVF cells. Human 
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skin-derived dermal fibroblasts (HDF) and keratinocytes (KC) were isolated and expanded 
from foreskin (males between 2 and 18 years of age) as previously described [2].  
 
Cell characterization 
The phenotype of freshly isolated SVF cells was determined by flow cytometry analysis. 
Cells were incubated for 30 min at 4°C in CM with different fluorochrome-conjugated 
antibodies against human CD31, CD34, CD73, CD90, CD146 (all from BD Bioscience, 
Franklin Lakes, NJ, USA) or CD105 (Serotec, Oxford, United Kingdom). Isotype IgGs were 
used as controls (all from BD Biosciences). After washing, cells were resuspended in FACS 
buffer (0.5% human serum albumin, 0.5 mM EDTA in PBS) and analyzed with a 
FACSCalibur flow cytometer (BD Biosciences). 
 
Preparation of vascDESS, non-vascDESS, and HDF-DESS  
Fibrin hydrogels were prepared using fibrinogen from bovine plasma (Sigma-Aldrich) 
reconstituted in 0.9% NaCl at a final concentration of 10 mg/ml. To achieve a comparable cell 
seeding inside the hydrogel, we seeded 3×10
5
 SVF cells, 7.5×10
4
 ASC, or 7.5×10
4
 HDF per   
3 ml gel. The concentration of SVF cells was optimized with respect to generating a 
functional and homogeneous dermal capillary plexus prior to transplantation. The 
corresponding prevascularized grafts started to be efficiently perfused 3-4 days after 
transplantation. The SVF contained 26±4% of mesenchymal and 28±9% of endothelial cells, 
whereas HDF or ASC-seeded gels contained 100% of stromal HDF or ASC cells, 
respectively. The table below demonstrates a comparison of cell population content between 
SVF, HDF, and ASC used for DESS transplantation experiment. 
% of cells SVF   HDF  ASC  
stromal cells 26±4 100 100 
endothelial cells 28±9 0 0 
 
The seeding density of the cells was normalized according to the number of mesenchymal 
cells, which were approximately four times higher in ASC than in the SVF. We seeded 1×10
5
 
SVF cells per 1 ml of hydrogel to reconstitute the dermal skin compartment [2-3, 43]. 
 Cells were centrifuged, resuspended in 100 µl EGM-2MV medium (Lonza, Basel, 
Switzerland) and mixed with 3 ml of the fibrinogen solution. The gels were placed in 6 well 
cell culture inserts with membranes of 3.0 μm pore-size (BD Falcon, Germany). 
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Polymerization was initiated by adding 33 µl of thrombin (Sigma Aldrich, 100 U/mL) and the 
gels were kept for 10 min at room temperature following by 1 h at 37°C in a humidiﬁed 
incubator containing 5% CO2. To prepare collagen hydrogels, rat collagen type I (BD 
Bioscience, Franklin Lakes, NJ, USA) was mixed with 0.2 ml neutralization buffer containing 
0.15 M NaOH [2-5]. After polymerization period, EGM-2MV was added to the upper and 
lower chambers of fibrin/collagen hydrogels, they were incubated for one or three weeks and 
analyzed for vascular network formation. To prepare dermo-epidermal skin substitutes 
(DESS) for transplantation, cells were cultured for two weeks in fibrin/collagen hydrogels in 
EGM-2MV medium, subsequently covered by keratinocytes (7.5×10
4
/gel), cultured for 
additional one week, and transplanted onto the immuno-incompetent rats (Supplementary 
Figure 1) [2]. Stromal cells (with or without EC) formed the dermal compartment, whereas 
keratinocytes constituted the dominating cell type in the epidermal compartment of DESS. As 
the dermal compartment of vascDESS was prevascularized in vitro, it contained already a 
mature network of human engineered capillaries.  
 
Transplantation of tissue-engineered skin substitutes 
The surgical protocol was approved by the local Committee for Experimental Animal 
Research (permission number 76/2011). Immuno-incompetent female nu/nu rats, eight to ten 
weeks old (Harlan Laboratories, Netherlands), were prepared and anesthetized as previously 
described (three independent donors for SVF (n=6 per condition; 18 rats) and ASC (n=6 per 
condition; 18 rats), and four for HDF (n=4 per condition; 12 rats) (in total 48 rats) [44]. DESS 
were transplanted onto full-thickness skin defects created surgically on the backs of the rats. 
 To protect the transplants and to prevent wound closure from surrounding rat skin, 
custom made steel rings (diameter 2.6 cm) were sutured into full-thickness skin defects 
created on the backs of the rats, using non-absorbable polyester sutures (Ethibond
®
, Ethicon, 
USA). The transplants were then covered with a silicone foil (Silon-SES, BMS, USA), a 
polyurethane sponge (Ligasano, Ligamed, Austria), a cohesive conforming bandage 
(Sincohaft, Theo Frey AG, Switzerland), and tape as wound dressing. By these means the 
bandaged site was fully protected and the rat could not scratch the transplant. Dressing 
changes and photographic documentations were performed once per week. After 4, 7, and 14 
days the transplanted skin analogs were excised in toto and processed for cryo- and paraffin 
sections, and electron microscopy.  
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Macroscopic assessment of the epidermal coverage area 
On day 4, 7, and 14 following surgery, the skin grafted areas were macroscopically assessed 
using planimetry [44]. Transplanted skin regions with whitish, smooth appearance were 
considered to be healthy epidermis, and calculated in all skin grafts: vascDESS (SVF) (n=6), 
non-vascDESS (ASC) (n=6), and HDF-DESS (HDF) (n=4) using computer software (NIH 
ImageJ) (http://rsb.info.nih.gov/ij/).  
 
Histological analysis  
Paraffin sections (5 µm) were stained with hematoxylin and eosin (Sigma-Aldrich) to assess 
the histological morphology in the transplanted DESS.  
 
Immunohistochemical staining 
Immunofluorescence staining was performed as described in Biedermann et al. and Montano 
et al. [3, 17]. Briefly, cells cultured on tissue culture plastic or cryosections were fixed and 
permeabilized in acetone for 5 min at -20°C, air dried, washed three times in PBS, and 
blocked with 2% BSA in PBS (Sigma-Aldrich) for 30 min. Incubation with the diluted 
antibodies was performed in blocking buffer for 1 h at room temperature. Slides were washed 
three times for 5 min in PBS and blocked for an additional 15 min before the second antibody 
was added. Finally, the slides were incubated for 5 min in PBS containing 1 μg/ml DAPI 
(Sigma-Aldrich), washed twice for 5 min in PBS, and mounted in Dako mounting solution 
(Dako, Baar, Switzerland). Sections of transplanted paraffin-embedded skin grafts were 
deparafinized (xylol, 3×10 min), dehydrated (ethanol 100–96–80–70–50%, 2 min each), and 
washed in PBS (3×5 min). The sections were boiled in citric buffer for antigen retrieval and 
incubated for 30 min in 0.1% Triton X-100 (Sigma Aldrich) and blocked in 10% BSA in PBS 
(Sigma-Aldrich) for 30 min. Immunostaining was performed using a primary antibody, or 
control IgG, followed by FITC or TRITC-conjugated secondary antibody (Dako, 
Switzerland). Pictures of immunofluorescence stainings were taken with a DXM1200F digital 
camera connected to a Nikon Eclipse TE2000-U inverted microscope. The device is equipped 
with DAPI-, FITC-, and TRITC-filter sets (Nikon AG, Switzerland; Software: Nikon ACT-1 
version 2.70). Images were processed with Photoshop 7.0 (Adobe Systems Inc, Germany). 
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Antibodies 
For immunofluorescence the following antibodies were used - from Abcam (Cambridge, 
UK): collagen type I (clone: ab6308, 1:100), NG2 (clone: ab83508, 1:100); from BD 
Pharmingen (Basel, Switzerland): Ki-67 (clone B56, 1:200), CD31 (clone TDL-3A12, 1:50); 
from Progen (Heidelberg, Germany): CK16 (clone LL025, 1:100), CK17 (clone: 61036, 
1:50); from Dako: CK19 (clone RCK108, 1:100), CD31 (clone JC7I, 1:150), αSMA (clone: 
M0851, 1:100); from R&D Systems Inc. (Minneapolis, USA): VE-cadherin-PE (clone: 
123413, 1:50); from Dianova (Germany): CD90 (clone AS02, 1:50); from Santa Cruz 
(Labforce AG, Nunningen, Switzerland): laminin 5 (clone P3H9-2, 1:100).  As a secondary 
antibody we used FITC or TRITC-conjugated immunoglobulins (Dako). For double 
immunofluorescence, some of the primary antibodies were pre-labeled with Alexa 488 or 
555-conjugated polyclonal goat F(ab′)2 fragments, according to the manufacturer's 
instructions (Zenon Mouse IgG Labeling Kit, Molecular Probes, Invitrogen).  
 
Whole-mount staining 
Fibrin/collagen hydrogels cultured with the SVF or ASC for one or three weeks in vitro were 
fixed in 4% PFA and analyzed for capillary network formation (n=9 samples; from three 
independent donors/experiments). Gels were blocked for unspecific binding and 
permeabilized with 0.1% Triton X-100/10% FBS for 1 h at room temperature, and incubated 
with rabbit anti-CD31, mouse anti-αSMA, mouse anti-VE-cadherin, mouse anti-NG2 
antibodies, and AlexaFluor 488 and 555-conjugated secondary antibodies (Invitrogen). 
Tissues were mounted in Dako mounting solution (Dako, Baar, Switzerland) for confocal 
imaging using a Leica SP1 confocal laser scanning microscope (Leica, Heerbrugg, 
Switzerland). Images were processed with Imaris 5.0.1 (Bitplane AG, Zurich, Switzerland). 
 
Electron microscopy 
For transmission electron microscopy analyses, fibrin hydrogels (samples of approximately 
1mm
3
) were prefixed in 0.1 M cacodylate buffer (Merck, Germany) (pH=7.3) containing 
2.5% glutaraldehyde for two hours, washed in cacodylate buffer, post-fixed with an aqueous 
solution of 1% OsO4 and 1.5% K4Fe(CN)6 for one hour, dehydrated, and finally embedded in 
EPON 812 (Catalys AG, Switzerland). Ultrathin sections (approximately 50-70 nm) were 
collected on copper grids, contrasted with 4% uranyl acetate and 3% lead citrate, and 
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examined with a CM 100 transmission electron microscope (Philips, The Netherlands). All 
reagents were from Sigma unless mentioned otherwise. 
 
Quantification of human capillary networks in vitro and in vivo 
Whole-mounted fibrin/collagen hydrogels or transplanted skin graft sections were imaged by 
the confocal microscope. Distinct vascular parameters (number of capillaries, branch points, 
average and total capillary length, capillary maturity level, perfused capillaries) were 
quantified per mm2 of hydrogel or transplant section using immunofluorescence staining 
against anti-human/rat CD31/αSMA antibody (n=6 per condition; from 3-4 independent 
donors/experiments). 3D confocal projection images were subjected to a series of image 
analyses (NIH ImageJ) allowing quantification of distinct parameters.  
The number of human erythrocyte-perfused CD31
+
 capillaries (auto-fluorescence of 
erythrocytes) was counted manually.  
 
Quantification of collagen content in vivo 
Deposition of collagen type I in the transplanted fibrin-derived skin grafts was visualized 
using anti-collagen type I immunofluorescence staining. For each sample, five sections (×10 
magnification were captured to quantify relative collagen deposition (n=4-6 per condition; 
from three/four independent donors/experiments). The positively stained area was measured 
using the same macroscopic settings and quantified using NIH ImageJ software. 
 
Quantification of neo-dermis thickness in vivo 
Sections stained with human specific CD90 antibody were captured using the same 
macroscopic settings (n=6 per condition; from three independent donors/experiments). The 
thickness of the neo-dermis (hCD90-positive region) was measured using ImageJ software-
based analysis. 
 
Quantification of number of proliferating cells in vivo 
Transplanted skin grafts were stained for Ki-67, and the ratio of proliferating nuclei (positive 
for Ki-67) over total nuclei (positive for DAPI) was quantified using ×20 magnification. In 
order to examine the proliferation rate of human EC, sections were co-stained for Ki67
 
and 
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hCD31
+
, and Ki67
+
hCD31
+
 cells were quantified over total hCD31
+ 
cells. Six microscopic 
fields at ×20 magnification were used in each group (n=4-6 per condition; from three/four 
independent donors/experiments). 
 
Statistical analysis 
All results are reported as mean ±SD. Statistical analysis was performed with GraphPad Prism 
4.0 (Graph Pad software, La Jolla, CA, USA). Comparison between two groups was 
performed using the unpaired Student’s t test.  
 
Results 
 
Characterization of the SVF and expanded ASC 
Distinct human SVF, harvested from five donors, consisted of a heterogeneous cell population 
(Fig. 1). Two different cell fractions were identified by cytofluorimetry: an endothelial 
(CD31+CD34+) one and a mesenchymal (CD73+CD90+) one (Fig. 1A, B). These findings 
confirm previously published data [37]. 
The CD31
+
CD34
+
 co-expression on the endothelial cell fraction was detected on 
approximately 28±9% of the whole SVF-population (n=5) (Fig. 1A). This CD31
+
CD34
+
 
endothelial cell fraction was further characterized by quantifying the co-expression of other 
markers, including CD90 (Thy-1) (85±8%) and CD105 (endoglin) (91±9%) - markers 
expressed both by stem/progenitor and endothelial cells, and CD146 (S-Endo-1/MCAM) 
(68±8%) - a cell marker expressed among others on mature endothelial cells (e.g. HDMECs).  
  To further evaluate the phenotype, morphology, and adherence to cell culture plastic 
of cell types present in the SVF, we grew them on tissue culture plastic overnight and 
performed analyses for lineage-specific markers (Fig. 1C-F). Phase contrast data shown in 
Fig. 1C illustrate a characteristic colony of cells containing both, epithelioid and spindle-
shaped cells. The colonies were typically surrounded by single spindle-shaped cells (white 
arrows). The colonies obviously consisted of CD31-positive cells and of cells positive for the 
stem/progenitor cell marker CD34, whereas only some of the single surrounding cells were 
CD34-positive and all were negative for CD31 (Fig. 1D). Figures 1E and F show that the 
colonies, in addition to vWF/CD31
+ 
endothelial cells contain cells positive for 
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mesenchymal/pericyte markers such as alpha-smooth muscle actin (αSMA) (Fig. 1E) and 
CD90 (Fig. 1F).  
  In vitro expansion of the SVF resulted in an adherent, homogeneous cell population 
that neither expressed CD31 nor CD34, hence the endothelial cell fraction was lost upon 
culturing. Instead all these cells co-expressed CD90 and CD73 (Fig. 1G, H). These data were 
confirmed by phase contrast microscopy (Fig. 1I) and immunofluorescence stainings 
revealing that the remaining population consisted of αSMA+ (Fig. 1K) and CD90+ (Fig. 1L) 
fibroblastic cells. These are commonly referred to as adipose-derived stromal cells (ASC) 
[37]. 
 
Vascular network formation in a 3D hydrogel in vitro 
The 3D cellular microenvironment is known to have a strong impact on stem cell 
differentiation and functionality [45-46]. Either the freshly isolated SVF or donor-matched 
adipose stromal cells (ASC) were submerged into 3D fibrin and collagen type I hydrogels and 
cultured for one, or for three weeks in vitro, respectively. The ability of fibrin and collagen 
scaffolds to support the spontaneous formation of a vascular network in vitro was evaluated 
(Fig. 2). We did not detect any differences in the morphology and capillary network 
characteristics using these two types of scaffolds (data not shown). 
After three weeks, confocal microscopy revealed branching capillaries in SVF-seeded 
fibrin hydrogels (Fig. 2A-D). In contrast, no microvascular structures were observed in the 
control group seeded with ASC. The specific staining for human endothelial markers, such as 
CD34, vascular endothelial cadherin (VE-cadherin), and CD31 confirmed that the EC 
population was not only retained within the 3D hydrogel, but also developed into capillaries 
(Fig. 2A-D, respectively). CD34
+ 
EC arranged into branching lumenized networks of 
microvessels occasionally originating from the centre (white star) of a given capillary 
arrangement (Fig. 2A). VE-cadherin expression was frequently detected in EC lining those 
capillaries (Fig. 2B). The lumen of the capillaries is marked in Fig.2 A and B by white 
arrows. 
As the development of true capillaries involves not only lumen formation, but also 
their stabilization by pericytes, we performed co-staining for pericyte- (αSMA, neuron/glia-
type 2 antigen (NG2)) and endothelial-specific marker (CD31), respectively (Fig. 2C, D). We 
found αSMA-positive cells (white arrows) closely associated with CD31+ capillaries (Fig. 
2C). However, αSMA-expressing cells were detected also at a distance from the capillaries 
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(Fig. 2C, white arrowheads). Pericyte-like cells expressing NG2 were wrapped around CD31
+ 
capillaries (Fig. 2D, white arrows) and were found exclusively at this perivascular location.  
 The formation of highly organized and mature capillaries in vitro was further 
confirmed by transmission electron microscopy (TEM) (Fig. 2E-G). A representative 
capillary cross-section in Fig. 2E shows several EC interconnected by intercellular junctions 
(green dotted lines), desmosomes (green arrowheads), and organized around a lumen [47-49]. 
  The presence of characteristic endothelial structures including caveolae (special type 
of lipid rafts; small invaginations of the plasma membrane) [50], pinocytic vesicles, as well as 
pseudopodia [51], were also observed (Fig. 2E, G). At the basal site of EC and pericytes, a 
basal lamina was deposited as demonstrated by yellow arrows (Fig. 2E, F). Pericytes appeared 
as polymorphic cells in a close contact with EC. Notably, characteristic contacts between 
endothelial and pericytic cells formed by cytoplasmic invaginations and interruptions in the 
capillary basement membrane, known as "peg-and-socket" junctions, were observed (Fig. 2E, 
F) [52].  
 To determine whether there was a significant difference in branching and capillary 
interconnections, EC-harboring fibrin hydrogels were examined either at one, or at three 
weeks after cell seeding (Fig. 3). Using immunofluorescence stainings for human CD31, four 
different quantitative parameters characterizing the extent of capillary formation and 
ramification, namely the number of vascular structures per mm
2
, branch points, as well as the 
total and average capillary length, were evaluated (n=9, from three independent donors). All 
parameters were significantly higher at three weeks as compared to one week, except the 
average capillary length (Fig. 3C-F). Consequently, the cells in fibrin hydrogels were cultured 
for three weeks before they were used for pre-clinical transplantation experiments. 
 
Engineered human blood capillaries are functional in vivo  
To demonstrate functionality of the human capillary plexus in vivo, hydrogels prevascularized 
by cells of the SVF were covered with human primary keratinocytes, now referred to as 
prevascularized dermo-epidermal skin substitutes (vascDESS), and transplanted onto the 
backs of immune-compromised rats (Supplementary Figure 1). Skin grafts containing donor-
matched adipose stromal cells (ASC) were used as a non-vascularized control (non-
vascDESS). The skin grafts were retrieved and examined at various time-points, namely 4, 7, 
and 14 days after transplantation (n=6 per condition, from three independent donors for both 
SVF and ASC).  
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Hematoxylin/eosin stainings of the sections of vascDESS revealed blood perfused 
capillaries as early as four days after transplantation (Fig 4A). There was a surprisingly high 
number of perfused capillaries at 7 and 14 days after transplantation (Fig. 4B, C), thus 
underlining the efficacy of the method. In contrast, non-vascDESS (control) did not contain 
any perfused capillaries at any time point (Fig. 4D-F). Already 4 days after transplantation, 
some human CD31
+
 capillaries were closely associated with rat CD31
+
 blood vessels (Fig. 
4G, a higher magnification is shown in Supplementary Figure 2). Human-rat chimeric vessels 
were even more apparent at day 7 and 14 after transplantation (Fig. 4H, I, respectively). In 
contrast, non-vascDESS, did not contain any human CD31-expressing capillaries at any time-
point (Fig. 4J-L), whereas ingrowing capillaries of rat origin were observed at 14 days after 
transplantation (Fig. 4L). Apparently these rat capillaries were not yet perfused at this time 
point since they did not contain erythrocytes.  
The dynamics of blood perfusion in capillaries formed by human EC in the 
transplanted vascDESS was evaluated. Sections of grafts from all independent studies (n=6 
per condition, three independent donors) were assessed by staining for human CD31 and 
subsequently quantified. At day 4 after transplantation, the total number of human capillaries 
per mm
2
 was significantly lower (13±4) than after 7 days (25±10), however the highest 
number was found 14 days after transplantation (45±12) (Fig. 4M and Supplementary Table 
1). Perfusion of the pre-existing human capillaries was analyzed based on the auto-
fluorescence of rat erythrocytes in human CD31-positive capillaries. At day 4 only about 
29±15% of all tissue-engineered capillaries were blood-perfused. The number of perfused 
capillaries increased to 82±20%
 
at day 7, and to 89±10% at day 14 (Fig. 4M and 
Supplementary Table 1). 
 
Maturation of tissue-engineered capillary networks in vivo 
To assess the maturation of tissue-engineered human capillaries in vivo, sections of grafts 7 
and 14 days after transplantation, were co-stained for the human endothelial marker (hCD31) 
and the pericyte marker (αSMA). The latter antibody recognized both human and rat αSMA 
(Fig. 5A-C and Supplementary Table 2). These analyses revealed that at day four after 
transplantation of vascDESS approximately 50±21% of human CD31
+
 capillaries were 
already associated with pericytes (Fig. 5C). At day seven, 80±6% of human capillaries were 
supported by αSMA-positive pericytes (Fig. 5A, C), and almost all human capillaries 
(96±5%) showed double-staining for CD31 and αSMA at day 14 (Fig. 5B, C).  
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The proliferation rate of EC in human capillaries in vivo was analyzed by using an 
antibody to Ki67, a nuclear protein expressed in cycling cells [53] (Fig. 5D-F). This antibody 
did not discriminate between human and rat Ki67-positive cells. Double-staining for hCD31 
and Ki67 showed an intensive phase of proliferation between day 4 and day 7, followed by a 
decrease at day 14 (Fig. 5D-F).  
 
Epidermal regeneration in vascDESS in vivo 
We hypothesized that increased neovascularization of vascDESS promotes epidermal 
development and functionality of the grafts in vivo. To prove this hypothesis, we 
macroscopically assessed the graft size in vivo by planimetry (Fig. 6A). Fig. 6A represents a 
macroscopic examination of vascDESS at day four after transplantation. Skin grafts 
containing ASC or human dermal fibroblasts (HDF) were used as a control (non/vascDESS 
and HDF-DESS, respectively) (n=6, from 3-4 independent donors). ASC and HDF-seeded 
gels contained only ASC or HDF cells, respectively, lacking endothelial cells. Engraftment 
was considered successful when the human epidermis on the graft was continuous, whitish, 
and smooth in appearance (Fig. 6A). By these criteria a complete take of all skin grafts was 
observed four days after transplantation within all the three groups containing SVF 
(vascDESS), ASC (non-vascDESS), or dermal fibroblasts (HDF-DESS). However, the 
planimetric analysis demonstrated that the graft size of the vascDESS group was significantly 
larger at day 4, day 7, and day 14, as compared to the non-vascDESS transplants (Fig. 6B) 
[54]. These results demonstrate that SVF-based prevascularization not only supported 
epidermal coverage, similar to HDF at day 4 and 7 following transplantation, but also reduced 
graft contraction as seen at day 14 (n=4-6 per condition).  
Dermal SVF, ASC, or dermal fibroblasts clearly promoted the stratification of 
keratinocytes, resulting in the formation of a multilayered epidermis containing a basal layer 
(Fig. 6C-K). However, differences in the morphogenesis and homeostasis of the in vivo 
regenerated epidermis were observed, suggesting that keratinocytes were affected by these 
three mesenchymal cell types. We evaluated the formation of a basement membrane at the 
dermo-epidermal junction by the presence of human specific laminin 5, and confirmed its 
expression in all three types of skin grafts (day 14 in vivo) (Fig. 6F-K, respectively). 
  Additionally, the wound healing and homeostasis markers were analyzed in the newly 
formed epidermis in vivo. Normal, homeostatic interfollicular epidermis lacks the expression 
of both cytokeratins (CK) 16 and 17 [3, 55-56]. They are, however, induced in suprabasal 
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keratinocytes in wound situations, including epidermal regeneration after transplantation. The 
staining for CK16 and 17 revealed that the period of wound healing was dramatically 
decreased in vascDESS (Fig. 6C, F), as compared to both control groups: non-vascDESS 
(Fig. 6D, G) and HDF-DESS (Fig. 6E, H). As for the duration of the wound healing status of 
the tested grafts this finding points to a significant difference between vascDESS and HDF-
DESS. 
  A major difference in the expression pattern of the skin homeostasis marker CK19 
was observed among the three skin transplant groups (Fig. 6I-K). In normal interfollicular 
epidermis of young children (up to 18 months in age), and in a certain state of our 
transplanted skin grafts, CK19-positive keratinocytes are clustered in the stratum basale, 
while in older children and adults these CK19
+
 cell clusters disappear completely [2]. In 
vascDESS (Fig. 6I) and HDF-DESS (Fig. 6K), the expression of CK19 was indeed confined 
to the epidermal basal cells, demonstrating a certain “intermediate” state of homeostasis, 
whereas in non-vascDESS (Fig. 6J), CK19-positive keratinocytes were still distributed in all 
suprabasal layers indicating that in these grafts tissue homeostasis was still far from being 
established [2]. 
 
Dermal remodelling of vascDESS in vivo  
To gain information on both the dimensions of the human neo-dermis in vascDESS, and the 
capillaries in it after transplantation, sections of transplanted vascDESS were stained for the 
human specific CD90 antigen (Fig. 7A). As demonstrated in Fig. 7A, engineered hCD31-
positive capillaries were abundant in the CD90
+
 neo-dermis of transplanted vascDESS. 
  In the following, we examined, whether the rapid vascularization of vascDESS had an 
effect on the thickness of the regenerating neo-dermis in vivo (Fig. 7B). Quantitative analyses 
revealed that the thickness doubled in vascDESS between day 4 and 7, and further increased 
at day 14. In comparison, the dermal regeneration process of non-vascDESS was delayed and 
led to a significantly thinner neo-dermis (n=6 per condition) (Fig. 7B). 
  The content of collagen type I was further evaluated in the grafts by immunostaining. 
Comparing the deposition of collagen I in vascDESS, non-vascDESS and HDF-DESS 
correspondingly in vivo, we consistently found the highest collagen content in vascDESS at 
all time points investigated (Fig. 7C). Of note, ASC cells in non-vascDESS showed a 
significantly higher capacity of collagen type I deposition during dermal wound healing than 
HDF.  
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As we observed a rapid and efficient vascularization and perfusion of vascDESS after 
its transplantation, we set out to determine a possible effect of this rapid nutrition on 
epidermal/dermal cell proliferation. For that the expression of Ki67 in the three types of skin 
grafts was investigated. These analyses revealed a significantly increased percentage of 
cycling, Ki67-expressing cells in both the epidermal and dermal compartment of vascDESS 
as compared to the two control groups (Fig. 7D). Taken together, these data are in line with 
the conclusion that the rapid perfusion of the tissue-engineered capillary plexus in vascDESS 
has clear positive effects on the reconstitution process of the respective transplanted skin 
grafts.  
 
Discussion  
 
The absence of functional vascular structures is still one of central hurdles in tissue 
engineering and regenerative medicine. Tissue-engineered dermo-epidermal skin grafts 
(DESS), let alone any off-the-shelf products, although only still rarely applied in the clinic, 
are usually not prevascularized. As a consequence, even these very promising grafts, 
representing a surgical option at the forefront of plastic and burn surgery, are still dependent 
on diffusion (imbibition) in the first weeks upon transplantation until vascular ingrowth from 
the host site occurs. Accordingly, they experience a physiological crisis because of impaired 
nutrition, oxygen and growth factor supply in the initial 2-3 weeks after transplantation. This 
may well result in an expanded and somewhat misdirected phase of regeneration followed by 
fibrosis and other scar-like formations. 
The goal of this study was to introduce a prevascularized, dermo-epidermal skin graft 
to be used clinically in an autologous and permanent fashion. The starting cell population was 
derived from the SVF isolated from human adipose tissue. There are several lines of evidence 
showing that cells from the SVF can spontaneously develop a microvasculature in vitro and in 
vivo [37, 57-58]. However, the mechanism of how SVF cells assemble into a capillary plexus, 
still remains unclear. Although endothelial cells play a crucial role in this process, they are 
not sufficient to establish a mature vascular network either in vitro [59] or in vivo [60]. As 
demonstrated in our study, and by others, at least a second (mesenchymal) cell type is 
necessary to foster the formation of stable and functional vascular networks [59, 61]. We 
show in this study that it is a peculiar and very convenient feature of the SVF that the ratio of 
cell types involved in capillary formation is intrinsically optimal and constant, ideally 
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supporting the development of capillary networks in fibrin or collagen hydrogels. This is in 
contrast to human dermal microvascular endothelial cells, HDMEC, which develop into 
capillaries when co-seeded with human dermal fibroblasts in a ratio of 1:1 within fibrin 
hydrogels [17]. Adjusting and maintaining the ratio of 1:1 is a labour-intensive process, and in 
contrast to the well balanced ratio of vasculogenic cell types of the SVF, this ratio can not be 
easily maintained in culture. Consequently, the dermal fibroblasts overgrow and dominate the 
graft. This may largely interfere with the development of capillary networks.  
We show here that the optimal vasculogenic properties of the SVF were an exclusive 
feature of fresh SVF isolates and that culturing has a negative impact on the initial 
characteristics of SVF cells. This was indicated not only by the significantly impaired 
capillary formation, but also by the position of the cells in the de novo formed vasculature. 
Endothelial and perivascular cells were derived from fresh SVF isolates, whereas mostly 
perivascular cells were derived from cultured SVF. Flow cytometry of select markers revealed 
high expression of CD31 and CD34 in cells of fresh SVF isolates. However, both markers 
were rapidly downregulated upon 2D culture, suggesting a loss of endothelial cells as 
previously observed [37]. This reduction resulted in a lower density of newly formed 
capillaries by the cultured SVF cells in vivo and is consistent with the idea that the endothelial 
cells present in SVF cell isolates are required for capillary formation [57]. As pointed out by 
Traktuev et al. and Lin et al. the proportion of cells exhibiting a perivascular phenotype 
(αSMA+ cells) does not change with culture [62-63]. This is again consistent with the finding 
that cultured SVF, hence ASC, preferentially incorporate as mural cells into angiogenic 
neovessels [63]. 
As already mentioned above, the endothelial cell fraction is usually rapidly lost in 2D 
cultures. We managed to expand and maintain the endothelial cell fraction of the SVF, by 
integrating it into a previously developed tissue-engineered, hydrogel-based, 3D dermo-
epidermal skin graft [2, 5, 64]. In such a permissive environment, SVF cells formed 
spontaneously and de novo a mature microvascular plexus, which thereafter became denser 
and more ramified. Interestingly, the histological composition of these capillaries was similar 
to the composition of normal human capillaries, exhibiting normal sized lumina, pericyte 
coverage and organotypic microstructures, such as a basal lamina, "peg-and-socket" junctions, 
pseudopodia, caveolae, pinocytotic vesicles, and complex intercellular junctions. Of note, 
these specific features confirmed ultrastructurally the presence and interaction of EC and 
pericytes in the engineered vascular structures  
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Importantly, the tissue-engineered capillary plexus served as a functional (dermal) 
vascular interface between the recipient’s circulation and the epidermis (the epithelium) of the 
DESS. Notably, the connection between the rat microvascular system and the human tissue-
engineered vascular plexus occurred as early as 3-4 days after transplantation of the DESS. 
This rapid perfusion resulted in several positive effects (in comparison to non-vascDESS), 
which were: a) the significant increase of the transplanted dermo-epidermal area, indicative of 
the absence of shrinkage, most likely due to the efficient blood supply, b) increased collagen 
type I deposition, c) increased cell proliferation of both dermis and epidermis, hence an 
increased thickness of both tissues, d) reduced and shorter expression of typical wound 
healing markers, such as CK16 and CK17, e) significantly faster establishment of epidermal 
homeostasis. All these positive effects are important prerequisites for the clinical use of the 
SVF. In particular, the significantly reduced contraction of vascDESS may mean a major 
clinical improvement [65]. Contraction is especially dramatic in young patients, namely in the 
areas of the joints, which forces these patients to undergo repetitive, painful surgeries, and 
long hospitalization time. 
In addition, the SVF is relatively abundant and accessible in comparison to other adult 
autologous cell sources and can be used directly after tissue harvest and cell isolation, without 
in vitro expansion. Furthermore, multiple Phase I clinical trials using adipose-derived SVF are 
suggesting that these cells are safe and can be efficiently transplanted in either an autologous 
or allogeneic manner [66-67]. Given these facts together with the notion that a single-cell 
source can give rise to efficient vascularization of a tissue-engineered graft makes this 
approach practical and clinically very attractive. 
 
Conclusions 
Our study provides a key improvement in maintaining the endothelial cell population of the 
stromal vascular fraction (SVF) in 3D hydrogels, which is otherwise rapidly lost in 2D 
culture. We present a detailed analysis of the de novo formation of SVF-based microvascular 
networks, their maturation, and integration into dermo-epidermal skin grafts. After 
transplantation, these preformed capillaries prove to be a key stimulator of rapid blood 
perfusion and dermo-epidermal regeneration. We conclude that the adipose-derived SVF 
represents a convenient source of endothelial cells and pericytes. Submerged within an 
appropriate 3D environment, these cells allow the in vitro prevascularization of human 
autologous dermo-epidermal skin grafts, which are a great promise for clinical use.  
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Figures and Tables 
Figure 1. Characterization of the SVF and expanded ASC. (A, B) Freshly isolated SVF cells were co-stained for 
endothelial (CD31, CD34) (A) and mesenchymal (CD90, CD73) markers (B), and analyzed by flow cytometry. 
(C) Representative phase-contrast image of freshly isolated SVF cells seeded on tissue culture plastic. The white 
dotted line indicates an endothelial cell colony. White arrows mark spindle-shaped cells that surround this 
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colony. (D-F) Representative merged fluorescence images of CD31 and CD34 expressing cells (D), vWF and 
αSMA (E), as well as CD31 and CD90 (F). (G, H) Monolayer-expansion of SVF cells resulted in a homogenous, 
adherent population composed of adipose stromal cells (ASC) negative for the endothelial markers: CD31 and 
CD34 (G), and positive for the mesenchymal markers: CD90 and CD73 (H) as revealed by flow cytometry. (I) 
Phase-contrast micrograph of ASC at passage three expanded on cell culture plastic. (J-L) Merged fluorescence 
images of ASC expressing CD31 and CD34 (J), vWF and αSMA (K), and CD31 and CD90 (L). For (A, B) and 
(G, H) dot plot analyses represent the average values (±SD) of the gated populations calculated from five 
independent donors. DAPI stains the nuclei in blue. Abbreviations: ASC: adipose stromal cells; αSMA: alpha-
smooth muscle actin (pericyte marker); vWF: von Willebrand factor (endothelial marker). Scale bars=100µm. 
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Figure 2. Cells of the SVF form complex vascular networks in vitro. (A, B) Confocal images of human SVF-
derived capillaries cultured three weeks in vitro in a 3D fibrin hydrogel, and stained for endothelial-specific 
markers such as CD34 (A) and VE-cadherin (B). Arrows indicate lumenized capillaries (A, B). The white star in 
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(A) marks the center of a stellate-shaped capillary formation. (C, D) Pericytes are associated with endothelial 
cells as demonstrated by double-labeling for CD31 and αSMA (C) and CD31 and NG2 (D). White arrows 
indicate αSMA+/NG2+ cells directly associated with capillaries, whereas arrowheads mark αSMA+ cells which 
are not capillary-associated. DAPI stains the nuclei in blue. (E-G) Representative TEM micrograph of a mature 
capillary generated by cells of the SVF in vitro. (E) Cross-section through a capillary formed by several 
endothelial cells (EC) building an uninterrupted, complete endothelial lining around a lumen (L) covered by a 
pericyte (Pc), and basal lamina (yellow arrowheads). (F) and (G) are enlargements of the areas delineated in (E). 
(F) The pericyte forms extended, finger-like cytoplasmic processes interdigitating with the adjacent EC to form 
specific contacts termed "peg-and-socket" junctions (PS) indicated by red double arrows. (G) Black arrows mark 
characteristic endothelial structures including pseudopodia (Pd), caveolae (C) and pinocytotic (surface) vesicles. 
Blue arrows indicate vesicles which occur freely in the cytoplasm. Green dotted circles mark complex 
intercellular junctions that connect neighbouring endothelial cells and green double arrowheads desmosomes. 
Abbreviations: αSMA: alpha smooth muscle actin (pericyte marker); NG2: neuron/glia-type 2 antigen (pericyte 
marker); VE-cadherin: vascular endothelial cadherin (marker of endothelial adherens junctions); Nc: cell 
nucleus; TEM: transmission electron microscopy. Scale bars=100µm (A, C), 20µm (B, D), and 1µm (E, G). 
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Figure 3. Optimization of vascular network formation in vitro. (A, B) To determine the optimal culture time for 
maximal in vitro capillary network formation, fibrin hydrogels containing the freshly isolated SVF were stained 
using a human specific CD31 antibody at one (A) and three (B) weeks of culture. (C-F) Quantitative analyses of 
vascular structures determining the number of capillaries/mm2 (C), the number of branch points/mm2 (D), the 
total length of capillaries/mm2 (E), and the average capillary length/mm2 (F). All data are representative of three 
independent donors (n=9 per condition). Scale bars=100µm. 
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Figure 4. SVF-generated capillaries boost revascularization of vascDESS in vivo. (A-F) Hematoxylin/eosin 
stainings of vascDESS (containing cells of the SVF) and non-vascDESS (containing ASC) excised at 4 (A, D), 7 
(B, E), and 14 (C, F) days after transplantation (a.T). Note the presence of perfused vessels (erythrocytes are 
obvious in their lumen) exclusively in vascDESS, already at day four a.T. (inset in A). (G-I) Some of the tissue-
engineered human CD31-positive capillaries anastomosed as early as four days a.T. with the rat CD31-positive 
capillaries of the wound bed (G). By day 7 (H), the robust and lumenized human capillaries frequently 
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incorporated rat endothelial cells forming hybrid human/rat capillaries, which were colonized by rat vasculature 
at day 14 (I). Insets represent a high magnification view underlining the hybrid character of the capillaries. (J-L) 
Non-vascDESS did not stimulate ingrowth of rat vasculature before day 7 in vivo (J, K). Their neo-dermis was 
reasonably vascularized only 14 days a.T. (L). (M) Quantification of total and perfused human CD31 capillaries 
formed by the SVF at day 4, 7, and 14 a.T. in vascDESS. For (M) data are representative of three donors for 
SVF and ASC (n=6 per condition). White dotted lines indicate the dermo-epidermal junction (G-L). DAPI stains 
the nuclei in blue. Scale bars=100µm. 
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Figure 5. In vitro pre-formed SVF-capillaries organize into robust and mature capillary networks in vivo. (A, B) 
Immunofluorescence determination of human capillary maturation by co-staining for human CD31 and αSMA in 
vascDESS at day 7 (A) and 14 (B) a.T. (C) Quantification of total and mature (pericyte-associated) human 
CD31+ capillaries in vivo. (D-E) Immunostaining of human CD31-positive capillaries co-stained for the 
proliferation marker Ki67 in vascDESS. (F) Quantification of proliferating human endothelial cells (Ki67+ and 
hCD31+) in vascDESS in vivo. For (C, F) data are representative of three donors for SVF (n=6 per condition). 
DAPI stains the nuclei in blue. White dotted lines indicate the dermo-epidermal junction. Scale bars=50µm. 
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Figure 6. The SVF-based capillary plexus reduces shrinkage and accelerates the establishment of tissue 
homeostasis in vascDESS. (A) VascDESS (SVF) and non-vascDESS (ASC) at day 4 and 14 a.T. Black dotted 
lines indicate the area of each skin transplant used for planimetry analysis in (B). (B) Comparison of the areas 
covered by vascDESS with the two control groups, non-vascDESS and HDF-DESS respectively (in %), at day 4, 
7 and 14 in vivo (P<0.001 vasc- versus non-vascDESS). (C-E) Immunofluorescence staining of CK16 indicates a 
typical wound healing situation in (D, E), whereas in (C) tissue homeostasis is significantly more advanced. (F-
H) Co-expression of laminin 5 and CK17 confirms the data and conclusion of (C-E). (I-K) Laminin 5 and CK19 
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staining of the vascDESS and both control groups 14 days a.T. demonstartes that in non-vascDESS tissue 
homeostasis is delayed. For (B) data are representative of three donors for SVF and ASC (n=6 per condition), 
and four donors for HDF (n=4 per condition). DAPI stains the nuclei in blue. White dotted lines indicate the 
dermo-epidermal junction (C-K), white arrow the thickness of the epidermis (E). Abbreviations: CK: 
cytokeratin; HDF: human dermal fibroblasts; Lam5: laminin 5. Scale bars=1cm (A) and 100µm (C-K). 
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Figure 7. SVF-derived capillaries accelerate dermal regeneration in vascDESS. (A) The dimension (thickness) 
of a representative, highly vascularized neo-dermis of human origin in vascDESS is visualized by the human 
specific CD90-antibody co-stained by human CD31 at day 7 a.T. (B) The thickness of the neo-dermis increases 
in vascDESS in vivo. (C) Evaluation of dermal collagen type I deposition (in %) in vascDESS and the two 
control groups (non-vascDESS and HDF-DESS) in vivo. (D) Percentage of dermal and epidermal Ki67+ 
proliferating cells in vascDESS and both control groups in vivo. For (B), (C), and (D) data are representative of 
three donors for SVF and ASC (n=6 per condition), and four donors for HDF (n=4 per condition). The thickness 
of the epidermis is indicated by white arrow (A). DAPI stains the nuclei in blue. Scale bar=100µm. 
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Supplementary material 
Supplementary Figure 1. Experimental study design. The vascDESS were prepared by embedding the freshly 
isolated SVF within 3D fibrin/collagen hydrogels allowing assembly into capillary networks within the dermal 
compartment (two weeks in vitro culture). Subsequently epidermal keratinocytes were seeded on the gels to form 
an epidermis (one week in vitro culture). Thereafter the grafts were transplanted onto immuno-incompetent rats. 
Non-vascDESS containing donor-matched adipose-derived stromal cells (ASC), as well as cell-free scaffolds 
were used as controls. At day 4, 7, and 14 after surgery, skin grafts were retrieved for macroscopic and 
histological analysis. 
 
 
 
 
 
   RESULTS – PUBLICATION I 
 
 59 
Supplementary Figure 2. Confocal image of anastomoses between human and rat capillaries. Merged image 
showing the extensive connection between human and rat CD31-positive capillaries at day four post-grafting. 
Scale bar=50µm. 
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Supplementary Figure 3. Confocal image of total vs. perfused vessels at different time points. Immunostaining 
of total human CD31-positive capillaries after 4 (A), 7 (B), and 14 days (C) following transplantation. Some of 
these capillaries contain red erythrocytes (shown by autofluorescence) in their lumina, demonstrating the 
functional blood flow. White dotted lines indicate the dermo-epidermal junction. DAPI stains the nuclei in blue. 
Scale bar=50µm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   RESULTS – PUBLICATION I 
 
 61 
Supplementary Table 1. Quantification of human capillaries in vascDESS in vivo. All data are representative of 
three donors for SVF and ASC (n=6 per condition). The ratio of perfused vessels to total vessels is expressed as 
%. P-values compare day 7 versus day 4, and day 14 versus day 7 (Student’s t test). 
 
 
Supplementary Table 2. Quantification of total (hCD31+) and mature human (hCD31+αSMA+) capillaries in 
vascDESS in vivo. All data are representative of three donors for SVF (n=6 per condition). The ratio of mature 
to total human capillaries is expressed as %. P-values compare day 7 versus day 4, and day 14 versus day 7 
(Student’s t test). 
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4.2 Optimizing in vitro culture conditions leads to a significantly shorter 
production time of human dermo-epidermal skin substitutes 
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Abstract  
 
Introduction: Autologous dermo-epidermal skin substitutes (DESS) generated in vitro 
represent a promising therapeutic means to treat full-thickness skin defects in clinical practice. 
A serious drawback with regard to acute patients is the relatively long production time of 
three to four weeks. With this experimental study we aimed to decrease the production time of 
DESS without compromising their quality. 
Methods: Two in vitro steps of DESS construction were varied: the pre-cultivation time of 
fibroblasts in hydrogels (1, 3, and 6 days), and the culture time of keratinocytes (3, 6, and 12 
days) before transplantation of DESS on nude rats. Additionally, the impact of the air-liquid 
interface culture during three days before transplantation was investigated. Three weeks after 
transplantation, the macroscopic appearance was evaluated and histological sections were 
produced to analyze structure and thickness of epidermis and dermis, the stratification of the 
epidermis, and the presence of a basal lamina. 
Results: Optimal DESS formation was obtained with a fibroblast pre-cultivation time of 6 
days. The minimal culture time of keratinocytes on hydrogels was also 6 days. The air-liquid 
interface culture did not improve graft quality. 
Conclusion: By optimizing our in vitro culture conditions, it was possible to very 
substantially reduce the production time for DESS from 21 to 12 days. However, pre-
cultivation of fibroblasts in the dermal equivalent and proliferation of keratinocytes before 
transplantation remain crucial for an equilibrated maturation of the epidermis and cannot be 
completely skipped. 
Keywords: Tissue-engineering - Dermo-epidermal skin substitutes - Skin reconstruction - Air-
liquid interface - Collagen hydrogels  
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Introduction 
 
Cultured skin substitutes have been used in both experimental and clinical settings for over 40 
years [1]. In the global picture, culture time was always between 3-4 weeks, independent of 
what type of skin substitute was produced (cultured epithelial autografts (CEA) alone [2-5], 
CEA+allografts [6]), or cultured skin substitutes (CSS) [7-8]. 
 For obvious reasons, culture time does not play a dominant role when a cultured skin 
substitute is transplanted onto a patient undergoing elective plastic or reconstructive surgery 
since the patient can be called in for the operation when the graft is ready. In contrast, culture 
time does play a crucial, potentially even vital, role when cultured skin substitutes are to be 
applied on acute and massive burn patients. Therefore, a significant reduction of culture time 
would represent a substantial progress provided the more rapid production is not associated 
with quality loss. Here, we present a culture modality to minimize culture time of tissue-
engineered human cell-derived dermo-epidermal skin substitutes (DESS) suitable for clinical 
application. 
 
Material and Methods 
 
Primary cell cultures 
Human skin samples from scalp, eyelid, neck or foreskins were obtained from patients aged 
between 4 months and 56 years (Tab. 1). Approval was obtained from the Ethics Committee 
of the Canton Zurich and informed consent was given by parents or patients. Keratinocytes 
and fibroblasts were isolated, cultured, and stored in liquid nitrogen until needed as 
previously described [9].  
 
Organotypic cultures and transplantation of cultured dermo-epidermal composites: 
standard procedure 
Organotypic cultures and transplantation experiments were performed as previously published 
[9] with some modifications: hydrogels were prepared by mixing 0.6 ml chilled neutralization 
buffer containing 0.15 M NaOH [10], 0.3 ml DMEM/10%FCS containing 40'000 fibroblasts 
and 2.1 ml of rat tail collagen type I (3.2-3.4 mg/ml, BD Biosciences, Allschwil Switzerland) 
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into 4.2 cm
2
-cell culture inserts (BD Falcon, Basel, Switzerland; [11]). After jellification (10 
min at room temperature and 2 hours at 37°C) the thickness of the dermal equivalents was 
reduced from 7 to 1 mm by compression [12] and grown in DMEM/10%FCS for 1 to 6 days. 
 Subsequently, keratinocytes were seeded onto each dermal equivalent at a density of 
125x10
3
 cells per cm
2
 within polypropylene rings of 5 mm in diameter. After 6 hours the 
rings were removed and culture medium was added in the upper and lower chamber. The skin 
equivalents were cultured for two weeks; 3-4 days before transplantation on nude rats [9], the 
substitutes were raised to the air/liquid interface. 
 
Variations of the standard protocol: experimental schedule 
In the first experiment, the pre-incubation time of fibroblasts in the dermal template was 
modulated (Fig. 1A). We isolated fibroblasts from foreskin or neck skin biopsies of three 
different patients and cultured them to passage 1-2. The age of the patients varied between 4 
months and 2 years (Tab. 1). One, 4, or 6 days before the pre-determined date of keratinocytes 
seeding (green squares) fibroblasts were included in collagen I hydrogels. At day 0 (black 
dots), foreskin-keratinocytes were applied onto the hydrogels and cultured for two weeks 
before transplantation (TRX). 
In the second part of the experiment, the pre-incubation time of fibroblasts in the 
dermal template was maintained constant at 7 days (Fig. 1B).  Thereafter, at day 0 (red dot) 
keratinocytes were seeded on the hydrogels and incubated for 3, 6, or 12 days before 
transplantation. Two sets of the 6- and 12-days series were produced. One of them was 
exposed to the air-liquid interface 3 days before transplantation (Fig.1C), while the other 
remained submerged (Fig. 1B). In all experiments, grafts were removed for analysis 3 weeks 
after transplantation. 
 
Fluorescein diacetate (FdA) vital cell staining 
In order to visualize cell viability and homogenous epidermal cell coverage of the hydrogels, 
FdA staining was performed as published [13]. Briefly, from an acetone 5 mM-stock solution, 
FdA (Sigma, Buchs, Switzerland) was added to the culture medium in the lower and upper 
chamber to a final concentration of 5 μM. After 2 min FdA was removed by washing twice in 
PBS before fresh culture medium was applied. The substitutes were analysed by fluorescence 
microscopy. 
RESULTS – PUBLICATION II 
 
66  
Histology and immunofluorescence microscopy  
The epidermal substitutes were prepared to produce cryo- and paraffin sections. Histology 
and three-color immunofluorescence stainings were performed as previously described. For 
details refer to Biedermann et al. [9].  
 
Antibodies 
For the purpose of determining DESS quality, antibodies to the following markers were 
applied for immunofluorescence stainings:  
Involucrin (clone SY5, 1:100; LabVision, P.H.Stehelin&CIE AG, Basel, Switzerland) is a 
marker for the cornification process and is associated with the formation of desmosomes and 
intermediate filaments in the granular layer [14]. It is expressed (in homeostatic conditions) in 
the granular and cornified layer. K1 (clone LHK1, 1:200; Chemicon) as late differentiation 
marker [15] is indicative of the degree of tissue homeostasis in normal human skin, where it is 
expressed in all suprabasal layers, with exception of the stratum corneum. Occludin 
(polyclonal, 1:50; Zymed, Invitrogen, Basel, Switzerland) is indicative for the formation of 
tight junctions in the granular layer. It represents a further confirmation of acquiring terminal 
functionality of the epidermis. α6 integrin (clone 4F10, 1:100; Chemicon, Millipore AG, Zug, 
Switzerland) is a component of hemidesmosomes and assures the stable anchorage to the 
basal lamina [16]. It is indicative for the quality of the dermo-epidermal junction. K19 (clone 
RCK108, 1:100; Dako, Baar, Switzerland) and K15 (clone spm190, 1:50; Santa Cruz, 
Labforce AG, Nunningen, Switzerland) are markers for a mature basal layer and general 
homeostasis: In homeostatic engineered epidermal substitutes K19-positive cells are clustered 
in the stratum basale as a subpopulation of K15-positive keratinocytes [11]. As a secondary 
antibody we used FITC-conjugated polyclonal goat F(ab’)2 fragments directed to mouse 
immunoglobulins (Dako).  
 For double immunofluorescence, some of the primary antibodies were pre-labeled 
with Alexa 555-conjugated polyclonal goat F(ab’)2 fragments, according to the instructions of 
the manufacturer (Zenon Mouse IgG Labeling Kit, Molecular Probes, Life Technologies, 
Zug, Switzerland). 
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Statistical Analysis 
The thickness of epidermis and stratum corneum as well as the graft size were measured in 3 
different representative areas. All results are reported as mean ± standard deviation. Statistical 
analysis was performed with GraphPad Prism 4.0 (Graph Pad software, La Jolla, CA, USA). 
Comparison between two groups was performed using the unpaired Student’s t-test. Results 
were considered significant with a p < 0.05. 
 
Results 
 
Fibroblasts precultivation time 
Immediately before transplantation we verified the presence of an epidermis via FdA staining. 
Fig. 2A shows the staining of the second series of substitutes (Tab. 1). Similar results were 
obtained with series 1 and 3: keratinocytes proliferation was more pronounced on the 
hydrogels which were conditioned by fibroblasts for 6 days (6dF): the whole surface of the 
gels was homogeneously covered (left panel), starting from a circle of 0.96 mm in diameter in 
the centre of the dermal template (dotted circle). A shorter pre-incubation of the fibroblasts of 
4 days (4dF) or 1 day (1dF) was less supportive for keratinocytes proliferation (middle and 
right panel). 
Three weeks after transplantation (Fig. 2B), the 6dF-DESS looked macroscopically 
more developed and the presence of the hydrophobic stratum corneum was clearly visible 
(left panel). Correspondingly the measurement of the graft area showed that 87±16% of the 
original graft size was maintained (Fig. 2C). In contrast, in 4dF and 1dF-DESS the graft area 
was reduced to 35±17%, and 6±5%, respectively (Fig. 2C).  
Histological analyses confirmed in 6dF-DESS the formation of a stratified epidermis, 
which consisted of a stratum basale (sb), 12–20 suprabasal layers comprising stratum 
spinosum (ss) and stratum granulosum (sg), and a well-differentiated anuclear stratum 
corneum (sc, Fig. 3A). In 4dF-DESS, the epidermal thickness was reduced (middle panel).  In 
1dF-DESS, no epithelium was found (right panel). 
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Stratification markers in engineered DESS 
As a complement to the morphological analysis, we verified the presence of some protein 
expression markers which are indicative for the grade of homeostasis of an engineered 
epidermal substitute.  
We found involucrin expression (Fig. 3B, red stain) in the stratum spinosum of the 
substitutes, indicating a still ongoing differentiation process in 6dF-DESS (Fig. 3B, left). The 
thinner epidermis in 4dF showed a similar expression pattern (Fig. 3B, center). No involucrin 
expression was found in the in 1dF (Fig. 3B, right). 
Both 6dF and 4dF showed a strong expression of K1 (Fig. 3B, green stain, left and center) in 
all suprabasal layers, with exception of the cornified envelope. In 1dF, only few K1-
expressing epithelial cells were visible (Fig. 3B, right).  
Occludin (Fig. 3C, green) was expressed in the upper stratum granulosum of 6dF and 
4dF (left and center), but absent in 1dF (right). Integrin α6 staining (Fig. 3C, red) demarcated 
the dermo-epidermal junction in 6dF and 4dF, but was not visible in 1dF. 
Fig. 3D shows that in 6dF and 4dF, but not in 1dF, K19-positive cells (red), are 
present in the basal layer as a subpopulation of K15-positive keratinocytes (green).  
 
Keratinocyte pre-cultivation time 
The second step of DESS generation consisted in the seeding of keratinocytes on the pre-
cultivated hydrogels. We now varied the incubation time of keratinocytes on the dermal 
substitutes (and so the degree of pre-stratification of the graft) before transplantation while the 
pre-cultivation time of the fibroblasts in the gels was maintained identical (Fig. 1B). Fig. 4A 
illustrates the macroscopic overview of the two series of DESS three weeks after 
transplantation. The DESS generated with a three day keratinocyte (3dK) pre-cultivation time 
(left panels) do not show a hydrophobic, dry cornified surface. In contrast, the skin analogues 
formed with a 6 day (6dK) keratinocyte precultivation time show a cornified surface (center). 
Importantly 12 day (12dK) pre-cultivativation of DESS did not improve the outcome: vessels 
were locally visible under the substitute (right panels, arrow) indicating a reduced epidermal 
thickness. Fig. 4B statistically illustrates the measured size of the substitutes, pictured in Fig. 
4A.  
H/E-staining of 3dK confirmed the presence of a thin epidermal coverage in some 
areas, while in other areas no epidermis was found (Fig. 4C, left). 6dK produced a stratum 
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corneum and numerous keratinocytes layers (middle panels). 12dK showed a similar result, 
yet the thickness of the epidermis was reduced (right). 
 
Relevance of the air-liquid interface cultivation for transplantation 
The second set of 6dK and 12dK was raised to the air-liquid interface 3 days before 
transplantation (6dK
air
 and 12dK
air
 in Fig.1C). 
The graft size obtained from 6dk and 6dK
air
 respectively was similar in the first 
experimental series (75±2% vs. 74±3%) and slightly different in the second (52±5% vs. 
78±1%, p=0.0188) (Fig. 5A). The epidermal thickness was generally reduced in 6dK
air
 
(192±18 vs. 165±38 µm, not significant) but the cornification was more pronounced (38±11 
to 73±27 µm, p=0.0001) (microscopic view in Fig. 5B, and statistical analysis in Fig. 5C). 
The graft sizes obtained from 12dk and 12dK
air
 were different: 52±7% vs. 96±3% 
(p=0.0001) in the first series and 64±7% vs. 88±4% (p=0.0013) in the second (Fig. 5D). The 
epidermal thickness was similar in 12dK and 12dK
air 
(88±3 vs. 77±11 µm, not significant, 
Fig. 5F compares 5D) but again, the cornification was more pronounced in 12dK
air
 (27±6 vs. 
95±4 µm, p=0.0001) (microscopic view in Fig. 5E, and statistical analysis in Fig. 5F). 
 
Stratification markers in air-exposed DESS 
Immunofluorescence analysis of the expression pattern of stratification markers confirmed the 
high quality of both air-exposed and non-air exposed DESS. No difference in the expression 
pattern of K1/Involucrin (Fig. 6A), Occludin/integrin-a6 (Fig. 6B), and K15/K19 (Fig. 6C) is 
apparent. 
 
Discussion   
 
The principal goal of this study was to test whether the culture time for human cell-derived 
DESS can be significantly reduced when compared to standard procedures commonly used in 
our laboratory. The findings obtained clearly demonstrate that it is possible to markedly 
reduce the current culture time from 21 to 12 days. Hereby, the main gain was attributable to 
a significant shortening of the incubation time of keratinocytes on the dermal template before 
transplantation, i.e. from 14 to 6 days. 
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How can this significant reduction of incubation time be explained? We speculate that 
the specific cell biology dynamics of keratinocytes in culture (as opposed to keratinocytes 
residing in their natural habitat) play a role. For a more detailed understanding, we provide a 
description of our current culture system and the key phenomena observed during DESS 
formation: Once isolated and cultured, keratinocytes are seeded onto collagen hydrogels 
(=dermal templates). Then, keratinocytes start to proliferate and migrate horizontally to form 
a confluent layer on the top of the dermal template. Subsequently, the ongoing cell 
proliferation leads to formation of a multilayer that starts to stratify. Once the in vitro 
construct is raised to the air liquid interphase, cornification gradually develops. 
The above described processes typically last 14 days. Thereafter, our constructs are 
transplanted and usually produce an anatomically and functionally near normal skin [9]. We 
also know that if DESS incubation time is significantly lengthened to e.g. 21 days, quality and 
transplantation results are still satisfactory. If, however, DESS incubation time is further 
prolonged to 28 days or more, then we increasingly observed degenerative features ultimately 
leading to massive cell death and complete loss of DESS viability. 
In other words, the above mentioned evolution can roughly be described as an in vitro 
DESS life cycle comprising a “juvenile” (less than 14 d), a “mature” (14-21 d), and a “senile” 
phase (>21 d).  
The findings presented here clearly indicate that “juvenile” and not only “mature” 
DESS already have the potential to induce near normal skin after transplantation, i.e. 
following an only 6-day-long incubation time. Apparently, the 3-4 layers present at 6 days are 
sufficient to generate a normal epidermis after transplantation, i.e. there is no need to use 
“mature” DESS for a successful transplantation. 
To our knowledge, there is no information available regarding significantly shortened 
culture times for similar skin substitutes. The product most closely related to our DESS, the 
commercially available Apligraf
®
, uses allogeneic fibroblasts and keratinocytes. The 
allogeneic specification makes it possible to completely avoid any waiting time for the 
patient. Yet its production requires 20 days [17-18]. 
Other approaches drastically reduce or even skip in vitro cultivation: Starting from a 
small split-thickness skin biopsy, cell suspensions are applied onto the wound bed after 5 days 
of culturing or immediately after preparation (ReCell®) [19]. Yet, this strategy is definitely 
not appropriate to treat 3rd degree burns and, generally speaking, its place in clinical practice 
is still controversial. 
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The last consideration regards the fibroblast preincubation time. We could only realize 
a minor gain of 1 day with the reduction of the fibroblast pre-incubation time before seeding 
keratinocytes. As a matter of fact, the minimal duration of this phase is critical for correct 
DESS development. The presence of fibroblasts in the dermal template of DESS has been 
shown to be crucially important [20-22]. Fibroblasts remodel the collagen hydrogel, prepare 
the formation of a basal lamina and the anchorage of epithelial cells, secrete growth factors, 
and finally sustain epidermal regeneration [23]. To fulfil these tasks, fibroblasts need a 
defined minimal amount of time. It is generally assumed that raising the number of fibroblasts 
in the gel would accelerate the organization of the dermal template [24], but this acceleration 
may also be accompanied by abundant production of granulation tissue and wound 
contraction, both of which are unwanted effects [25]. Therefore, we believe that the fibroblast 
preincubation time cannot be significantly shortened. 
In summary and conclusion, this appears to be the first article to describe a very 
substantial shortening of the production time for laboratory grown human skin substitutes 
from 21 to 12 days without an obvious loss of graft quality. Our study may have important 
clinical implications in that a marked reduction of waiting time until autologous skin 
substitutes are ready for transplantation can definitely improve the fate of burn patients. 
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Figures and Tables 
 
 
Figure 1. Schematic representation of the experimental design. We evaluated modifications of our standard 
protocol for the in vitro-DESS construction in 3 steps. (a) In the first part of the study, fibroblasts were included 
in collagen I hydrogels and cultivated (green line) for 1 (1dF), 4 (4dF), and 6 (6dF) days before being covered by 
a keratinocyte sheet (black dot). After 2 weeks, DESS were transplanted (TRX) on nude rats and grafts were 
removed for analysis 3 weeks post transplantation. (b) In the second part of the study, fibroblasts were included 
in collagen I hydrogels and cultivated for 7 days before being covered by a keratinocyte sheet (red dot). After 
further cultivation (red line) for 3 (3dK), 6 (6dK), and 12 (12dK) days DESS were transplanted (TRX) on nude 
rats and grafts were removed for analysis after 3 weeks. (c) A second set of 6dK and 12dK were treated in the 
same way as in b), but they were exposed to the air-liquid interface 3 days before transplantation (6dK
+air
 and 
12dK
+air
) while the original DESS remained submerged.  
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Figure 2. Modulation of the pre-incubation time of fibroblasts in DESS: Effect on graft take in vivo. (a) 
Fluorescein diacetate (FdA) staining of one set of DESS immediately before transplantation (upper panels): The 
white dotted circles denote the keratinocyte seeding area. (b) Macroscopic view of the grafts 3 weeks thereafter. 
Scale bars = 5mm. (c) Graft size three weeks after grafting in % of the originally transplanted DESS (mean±SD, 
n=3). ***= p<0.0002.  
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Figure 3. Expression of structural markers for advanced epidermal histogenesis. (a) Eosin/Hematoxylin-stained 
paraffin sections of 6dF, 4dF, and 1dF-DESS 3 weeks after transplantation. bl: basal layer (arrow), sp: stratum 
spinosum, sg: stratum granulosum, sc: stratum corneum. (b) Immunofluorescence double-staining of 
cryosections with antibodies against cytokeratin K1 (green) and involucrin (red), (c) occludin (green), and 
integrin α6 (red), or (d) K15 (green) and K19 (red). Scale bar for all panels = 100 μm. 
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Figure 4. Variation of the incubation time of keratinocytes on the dermal substitutes before transplantation: 
Effect on graft take and stratification in vivo. (a) Macroscopic view of the grafts 3 weeks after transplantation. 
Both series of substitutes (refer to Tab. 1) are shown. Scale bar = 5mm. (b) Size of the transplanted DESS three 
weeks after grafting. Both series are included in the mean (mean±SD, n=6). ***= p<0.0001, n.s: not significant. 
(c) Eosin/Hematoxylin-stained paraffin sections of 3dK, 6dK, and 12dK-DESS 3 weeks after transplantation. 
The asterisk in 12dK of series 1 indicates a technical artefact. Scale bar = 50 µm. 
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Figure 5. Effect of air-liquid interface cultivation of DESS on graft take and stratification in vivo. (a,d) Size of 
the 6dK and 12dK (white) and 6dK+air and 12dK+air (grey) grafts three weeks after transplantation (mean±SD, 
n=3). Both experimental series are shown. (b,e) Eosin/Hematoxylin-stained paraffin sections of air-exposed 
(+air) and non-air exposed (-air) 6dK and 12dK 3 weeks after transplantation. Scale bar = 50 µm. (c,f) Thickness 
of the obtained air-exposed and non air-exposed 6dK and 12dK in µm (entire epidermis and stratum corneum 
only, mean±SD, n=3). ***= p<0.0001, **= p<0.0013, *= p<0.0188. 
 
 
 
 
 
 
 
 
 
 
   RESULTS – PUBLICATION II  
 
 79 
 
Figure 6. Stratification markers in air-exposed 6dK-DESS. (a) Immunofluorescence double-staining of 
cryosections with antibodies against K1 (green) and involucrin (red), (b) occludin (green) and integrin α6 (red), 
or (c) K15 (green) and K19 (red). Scale bar for all panels = 50 μm. 
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4.3 “Trooping the colour” - Restoring the original donor skin color by 
addition of melanocytes to bioengineered skin analogs 
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Abstract 
 
Purpose: Autologous skin substitutes to cover large skin defects are used since several years. 
Melanocytes, although essential for solar protection and pigmentation of skin, are not yet 
systematically added to such substitutes. In this experimental study we reconstructed 
melanocyte-containing dermo-epidermal skin substitutes from donor skins of different skin 
pigmentation types and studied them in an animal model. Features pertinent to skin color 
were analyzed and compared in both skin substitutes and original donor skin. 
Methods: Keratinocytes, melanocytes, and fibroblast were isolated, cultured, and expanded 
from skin biopsies of light and dark pigmented patients. For each donor, melanocytes and 
keratinocytes were seeded in different ratios (1:1, 1:5, 1:10) onto collagen gels previously 
populated with autologous fibroblasts. Skin substitutes were then transplanted onto full-
thickness wounds of immuno-incompetent rats. After eight weeks, macroscopic and 
microscopic analyses were conducted with regard to skin color and architecture. 
Results: Chromameter evaluation revealed that skin color of reconstructed light and dark 
pigmented skin was very similar to donor skin, independent of which melanocyte/keratinocyte 
ratio was added. Histological analyses of the skin analogs confirmed these findings.  
Conclusion: These data suggest that adding autologous melanocytes to bioengineered dermo-
epidermal skin analogs can sustainably restore the patients’ native skin color. 
Keywords: Melanocytes - Melanocyte/keratinocyte ratio - Tissue engineering – Skin analog - 
Skin color - Rat model 
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Introduction 
 
One promising approach to cover large full-thickness skin defects is tissue engineering of skin 
[1]. Several laboratories worldwide, including our own research group, have been working on 
this ambitious project and have made substantial progress over the last years [2-5]. At our 
center, we first used simple autologous cultured epidermal autografts (CEA) for burn and 
reconstructive surgery [6, 7]. However, they did not fulfill the expectations in that they 
showed inconsistent CEA take as well as inconsistent functional and aesthetic results.  
 Consequently, we invested several years on the development of a near natural dermo-
epidermal skin equivalent, based on the hypothesis that a skin substitute closely resembling 
native skin might ultimately produce more satisfactory clinical results [8-10]. Then, we 
managed to bioengineer capillaries in vitro in order to prevascularize skin substitutes [11]. 
Also, we looked at numerous options to strengthen the dermal compartment for better surgical 
handling and are now successfully working with a compressed hydrogel that serves as dermal 
template [12]. Finally, and with clinical application in mind, we developed a system to 
produce large scale (7.5 x 7.5 cm) skin analogs that were favorably tested in a large animal 
model (pig) [2, 3].  
 Most recently, we directed our work also at pigmentation that, for obvious reasons, is 
a crucial issue since it plays a fundamental functional role in terms of skin protection against 
ultraviolet (UV) radiation, and, additionally, it has a paramount cosmetic impact for the 
patient. If melanocytes, the cells responsible for skin pigmentation, are missing in skin 
analogs, the grafts appear unnaturally white like vitiligo-affected areas [13]. Therefore, we 
have designed a project with the principal goal to provide our autologous human skin analogs 
with appropriate pigmentation matching as closely as possible the native color present at the 
presumptive site of transplantation. To achieve this goal, we added human melanocytes in 
different ratios to the epidermal compartment of laboratory-engineered, human dermo-
epidermal skin analogs, tested these in a rat model, and compared the obtained pigmentation 
features to those of the original donor skin. 
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Materials and Methods 
 
Human skin samples 
The study was conducted according to the “Declaration of Helsinki Principles” and after 
permission by the ethic commission of the Canton Zurich. Parents or patients gave informed 
consent to use skin samples. The human foreskins used were obtained from light and dark 
skin pigmentation types from patients 1 to 16 years of age. The skin samples were used for 
the isolation of human epidermal keratinocytes, melanocytes, and dermal fibroblasts. Tissues 
samples for histological examinations were embedded in OCT compound (Sakura Finetek, 
Switzerland) and kept at -30 °C, or prepared for paraffin sections. 
 
Isolation and culturing of primary cells 
Keratinocytes and fibroblasts were isolated and cultured as described in Pontiggia et al. [10], 
melanocytes as specified in Böttcher-Haberzeth et al. [8]. 
 
Preparation of tissue engineered skin analogs 
The skin analogs were prepared as previously described [10]. Briefly, rat collagen type I was 
mixed with 1x10
5
 human dermal fibroblasts (passage 1) and placed in cell culture inserts with 
membranes of 3.0 μm pore-size (all BD Falcon, Germany). These dermal equivalents were 
grown in Dulbecco’s modified Eagle’s medium (DMEM, Invitrogen, Switzerland) for six 
days to allow for gel contraction. On each dermal equivalent 5x10
5
 keratinocytes and 
melanocytes (passage 1) of the corresponding donor skin were seeded in different ratios 
(melanocytes:keratinocytes 1:1, 1:5, or 1:10). The skin analogs were cultured for one week in 
a 1:1 mix of keratinocyte medium (SFM, Invitrogen, Switzerland) and melanocyte growth 
medium (Promocell, Germany), and subsequently transplanted (Table 1). 
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Table 1 Overview of the study design 
 Melanocytes:Keratinocytes 
1:1 
Melanocytes:Keratinocytes 
1:5 
Melanocytes:Keratinocytes 
1:10 
Light skin analogs 
N= 9 (total) 
1 4 4 
Dark skin analogs 
N= 9 (total) 
1 4 4 
 Number of skin analogs prepared for transplantation 
 
Transplantation of tissue engineered skin analogs 
The surgical protocol was approved by the local Committee for Experimental Animal 
Research (permission number 76/2011). Immuno-incompetent female nu/nu rats, eight to ten 
weeks old (Harlan Laboratories, Netherlands), were prepared and anesthetized as previously 
described [14, 15]. Skin analogs were transplanted onto full-thickness skin defects created 
surgically on the backs of the rats. To prevent wound closure from surrounding rat skin and to 
protect the skin analogs, surgical steel rings (26 mm in diameter) were sutured to the skin 
defects, using non-absorbable polyester sutures (Ethibond
®
, Ethicon, USA). The skin analogs 
were covered with a silicone foil (Silon-SES, BMS, USA), a polyurethane sponge (Ligasano, 
Ligamed, Austria), and a tape as wound dressing. Dressing changes and photographic 
documentations were performed once per week. After eight weeks the transplanted skin 
analogs were excised in toto and processed for cryo- and paraffin sections, and electron 
microscopy.  
 
Chromameter measurements 
The International Commission on Illumination (Commission internationale de l’Eclairage, 
CIE) principles of 1976 describes a uniform, three-dimensional color space (L*a*b*) because 
color vision is trichromatic. The L value correlates to perceived lightness. It can range from 
absolute black (0) to absolute white (+100). As it is the most sensitive of the trichromatic 
values to skin analog color change, only the L value (mean ± SD) of the reflectance 
spectroscopy used to measure the visible spectrum of light reflected from the patients’ 
foreskins and skin analogs was recorded in this study. The spectroscopy was conducted by 
employing a Chromameter CR-200 (Minolta, Osaka, Japan). 
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Histological analysis  
Paraffin sections (5 µm) were stained with hematoxylin and eosin (Sigma, Switzerland) to 
assess the histological morphology and with the Fontana Masson technique to visualize 
melanin [16] in the transplanted skin analogs.  
 
Immunohistochemical staining 
Immunofluorescence staining was performed as described in Böttcher-Haberzeth et al. [15], 
and Böttcher-Haberzeth et al. [8]. To detect melanosomes, an anti-melanosome antibody was 
used (HMB-45, 1:50, Dako, Switzerland). To visualize the basement membrane, a staining 
against laminin-5 was performed (clone P3H9-2, 1:100, Santa Cruz, Germany). Pictures of 
immunofluorescence stainings were taken with a DXM1200F digital camera connected to a 
Nikon Eclipse TE2000-U inverted microscope. The device is equipped with Hoechst 33342-, 
FITC-, and TRITC-filter sets (Nikon AG, Switzerland; Software: Nikon ACT-1 vers. 2.70). 
Images were processed with Photoshop 7.0 (Adobe Systems Inc, Germany). 
 
Electron microscopy 
For transmission electron microscopy analyses, tissue blocs (approximately 1mm
3
) were 
prefixed in 0.1 M cacodylate buffer (Merck, Germany), pH 7.3 containing 2.5% 
glutaraldehyde for two hours, washed in cacodylate buffer, postfixed with an aqueous solution 
of 1% OsO4 and 1.5% K4Fe(CN)6 for one hour, dehydrated, and finally embedded in EPON 
812 (Catalys AG, Switzerland). Ultrathin sections (approximately 50-70 nm) were collected 
on copper grids, contrasted with 4% uranyl acetate and 3% lead citrate, and examined with a 
CM 100 transmission electron microscope (Philips, The Netherlands). All reagents were from 
Sigma unless mentioned otherwise. 
 
Statistical analysis 
Melanocytes in the basal layer of the donor skin and of the skin analogs were evaluated by 
counting HMB-45 positive cells and cell nuclei (Hoechst staining) four times in each of five 
representative sections from each skin sample. The results were calculated (Microsoft Excel) 
to display the mean ± SD graphically.  
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Results  
 
Macroscopic appearance and color measurement of transplants 
Eight weeks after transplantation, the reconstructed human skin analogs from light and dark 
pigmented donor skin showed a strong resemblance to the latter regarding color and structure, 
independent of which melanocyte/keratinocyte ratio was used (Fig. 1). Pigmentation was very 
homogenous and even throughout the entire transplant of all specimens. The chromameter 
evaluation (L value) of the reconstructed light skin showed a mean deviation from the native 
light skin of 4.33% (SD 1.91%) for the constructs with a 1:1 melanocyte/keratinocyte ratio, of 
3.68% (SD 0.63%) for the constructs with a 1:5 melanocyte/keratinocyte ratio, and of 1.91% 
(SD 3.27%) for the constructs with a 1:10 melanocyte/keratinocyte ratio. The chromameter 
evaluation of the reconstructed dark skin showed a mean deviation from the native dark skin 
of 2.04% (SD 0.96%) for the constructs with a 1:1 melanocyte/keratinocytes ratio, of 3.26% 
(SD 7.94%) for the constructs with a 1:5 melanocyte/keratinocyte ratio, and of 0.71% (SD 
5.55%) for the constructs with a 1:10 melanocyte/keratinocyte ratio. 
 
Epidermal structure 
The epidermis of the constructs was comparable to the histology of the donor skin with regard 
to epidermal stratification, cellular differentiation, and absence of parakeratotic cells (Fig. 2). 
Results were very similar in both light and dark skin. A noticeable difference between the two 
was the heavily pigmented basal layer of the dark skin. An obvious difference between the 
analogs and the donor skin was the absence of rete ridges in the engineered skin. 
 
Melanocytes and melanogenesis 
HMB-45 staining visualized the melanocytes in the epidermis of the constructs (arrowheads 
Fig. 3). They resided in a physiologic position in the basal layer with contact to the basal 
membrane and projected dendrites into the upper layers of the epidermis (arrows Fig. 3). 
Fontana Masson staining demonstrated the typical melanin distribution within epidermal cells 
(supranuclear melanin cap) (Fig. 4). There were distinct differences between the light- and 
dark-pigmented constructs: There was more melanin in dark constructs and, in contrast to 
light constructs, melanin was found in all epidermal layers. Generally, the engineered 
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constructs showed similar melanin quantities and distribution to the donor skin, independent 
of which melanocyte/keratinocyte seeding ratio was used.  
By transmission electron microscopy, the melanosomes inside melanocytes and their dendrites 
as well as melanin inside keratinocytes was analyzed more in detail (Fig. 5): In the light skin 
analogs, melanocytes produced less melanin and lighter melanin granules in the 
melanosomes, whereas melanocytes in the dark skin analogs produced more melanin and 
darker melanin granules in the melanosomes. The keratinocytes of the light skin constructs 
contained less pigment than the ones of the dark skin constructs. In both analogs, melanin was 
arranged in a supranucelar position (supranuclear cap).  
 
Melanocyte density 
The melanocyte/keratinocyte ratio in the basal layer of all analogs was very similar to that in 
the corresponding donor skin. Results in both, the light- and dark-pigmented skin analogs, 
were independent of which melanocyte/keratinocyte ratio had been added initially (Fig. 6). 
 
Discussion 
 
This is an experimental study looking at the question whether the original, i.e. “constitutive”, 
skin color of a patient can be reproduced when melanocytes are added to tissue engineered 
full-thickness skin analogs. In particular, we looked at results of reconstructed light- and dark-
pigmented skin types when all cell types used (keratinocytes, melanocytes, and fibroblasts) 
were taken from the same donor skin and melanocytes were added in different ratios. 
Generally speaking, this study demonstrates that providing bioengineered skin analogs with 
melanocytes does in fact result in a skin color that is not only subjectively (photographic 
documentation) but also objectively (chromameter evaluation) almost identical to the color of 
the native donor skin. A number of aspects call for a detailed comment.  
 The fact that normal skin color is restored in our skin substitutes indicates that all 
sophisticated and often multi-step maneuvers from removal of the skin biopsy to cell isolation 
and culture, to assembling the substitutes, to transplantation, to middle-term maturation of the 
human transplanted skin in a rat model, do not seem to alter the involved cells (keratinocytes, 
melanocytes, and fibroblasts) in any measurable way. These cells apparently maintain their 
RESULTS – PUBLICATION III 
 
88  
inherent programs enabling them to communicate and interact with each other and work as a 
functional epidermal melanin unit (EMU) [17, 18]. 
 Interestingly, the above mentioned color production is independent of the original 
number of melanocytes added to the constructs. Even a significant deviation from the 
physiological 1:5 ratio of melanocytes to keratinocytes in the basal layer towards a higher 
(1:1) and a lower ratio (1:10) of melanocytes to keratinocytes, does not result in any 
measurable color difference. It is known that a minimum density of melanocytes is required to 
restore pigmentation completely [13]. In our analogs, this minimum number of melanocytes 
necessary to enable pigmentation of the skin was used. 
On a histological level, the macroscopic findings were precisely reflected. Particularly 
relevant is the fact that melanogenesis and the distribution of melanin transferred to 
keratinocytes very closely resembled the well-documented pattern known from physiological 
EMUs [19-21]. Also, the typical differences between light- and dark-pigmented skin types 
[21, 22], such as poorly pigmented supranuclear melanosomes and melanosome-free upper 
epidermis in light skin as well as heavily pigmented melanosomes throughout the cytoplasm 
of keratinocytes and melanosome presence throughout the entire epidermis in dark skin were 
largely replicated in our skin analogs.  
 Taken together, there is compelling evidence that adding melanocytes to 
bioengineered skin substitutes results in an almost physiological restoration of those cellular 
and molecular processes usually involved in the complex dynamics of skin pigmentation.  
The importance of using all three cell types (keratinocytes, melanocytes, and fibroblasts) from 
the same donor skin must also be highlighted. It is known that keratinocytes, melanocytes, 
and fibroblasts are highly interactive and communicate with each other via cell/cell contacts 
and secreted factors to regulate skin phenotype and functionality [21]. In this context, it is 
crucial to underline the importance of using these three key player cells from the same donor 
skin sample (as shown here) in order to reproduce the original skin color in bioengineered 
skin analogs. Interestingly, combining keratinocytes and melanocytes from one skin pigment 
type with fibroblasts from another skin pigment type results in disparate skin colors of 
engineered skin substitutes [22]. Clearly, for clinical applications, the requirement for fully 
autologous skin substitutes is indispensable for obvious reasons. 
 With regard to skin physiology, the novel possibility to provide tissue engineered skin 
analogs with a near natural color represents a significant progress not only in general terms of 
cosmesis, but especially in terms of cancer prevention and the potential to correct stigmatizing 
pigmentation defects [23, 24].  
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This study, however, does not address all important issues regarding this topic. First, we did 
not generate any data demonstrating that tissue engineered EMUs possess the ability to 
appropriately react to UV radiation. Definitely, the well-documented up- and down-regulation 
processes (e.g. PAR-2 receptor expression, melanin production) must be studied in this 
context [25-28]. Secondly, this study does not provide long-term data. Although the results 
shown here are amazingly physiological and although there are no obvious reasons why this 
functional capability should significantly change over time, formal long-term studies must 
address the question whether hypo- or hyper-pigmentation may occur over time [13, 29]. 
Finally, the evergreen-issue of whether manipulating melanocytes is associated with an 
increased risk of eventual melanoma-formation, must be mentioned. Even though our study 
period is definitely not sufficiently long to answer these questions and even though we have 
not looked in detail at markers used for melanoma diagnostic work-up (e.g. S100, Melan A, 
Ki67), we have not found any irritating histological features indicative of melanocyte 
dysplasia, such as epidermal cluster-formation or dermal compartment invasion. 
 In conclusion, this is, to the best of our knowledge, the first study demonstrating that 
adding autologous melanocytes to tissue engineered full-thickness skin analogs allows the so 
reconstructed skin to produce a near normal skin color almost identical to the native color 
present in the donor skin. It appears crucial that all three cell types originate from the same 
donor skin. These findings have significant clinical implications in that transplanting a skin 
analog containing functional EMUs is much more physiological, protects against harmful UV 
radiation, and improves cosmetic outcome. 
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Figures and Tables 
 
 
Figure 1. Macroscopic view of light and dark donor skin and its corresponding tissue engineered skin analogs 
eight weeks after transplantation. a Light and b dark donor skin before tissue preparation for cell isolation; c, e, g 
Tissue engineered skin analogs of light skin with a melanocyte/keratinocyte ratio of 1:1, 1:5, and 1:10; d, f, h 
Tissue engineered skin analogs of dark skin with a melanocyte/keratinocyte ratio of 1:1, 1:5, and 1:10. All 
analogs show a similar color to its donor skin, independent of which melanocyte/keratinocyte ratio was used 
initially. 
   RESULTS – PUBLICATION III 
 
 93 
 
Figure 2. Histological evaluation of light and dark donor skin and of excised corresponding tissue engineered 
skin analogs eight weeks after transplantation (haematoxylin and eosin staining). a Light and b dark donor skin; 
c, e, g Tissue engineered skin analogs of light skin with a melanocyte/keratinocyte ratio of 1:1, 1:5, and 1:10; d, 
f, h Tissue engineered skin analogs of dark skin with a melanocyte/keratinocyte ratio of 1:1, 1:5, and 1:10. All 
analogs show a well developed, stratified epidermis very comparable to the corresponding donor skin structure. 
In the dark skin analogs the heavily pigmented basal layer can easily be detected. Scale bars 50 µm 
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Figure 3. Melanocyte position in light and dark tissue engineered skin analogs eight weeks after transplantation. 
a Representative image of a light tissue engineered skin analog; b Representative image of a dark tissue 
engineered skin analog. Melanocytes are stained with HMB-45 (green), the basement membrane with Laminin-5 
(red), cell nuclei are stained with Hoechst (blue). Melanocytes are distributed throughout the basal layer 
(arrowheads) on the basement membrane. Dendrites can be seen projecting to the upper layers of the epidermis 
(white arrows). Scale bars 50 µm 
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Figure 4. Fontana Masson staining of light and dark donor skin and of the excised corresponding tissue 
engineered skin analogs eight weeks after transplantation. a Light and b dark donor skin; c, e, g Tissue 
engineered skin analogs of light skin with a melanocyte/keratinocyte ratio of 1:1, 1:5, and 1:10; d, f, h Tissue 
engineered skin analogs of dark skin with a melanocyte/keratinocyte ratio of 1:1, 1:5, and 1:10. Melanin granules 
stain black. Melanin quantity and distribution in skin analogs is very comparable to the corresponding donor 
skin, however, much more pronounced in dark skin analogs. Melanin is physiologically arranged as supranuclear 
caps in all transplants. Scale bars 50 µm 
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Figure 5. Ultrastructural evaluation of light and dark tissue engineered skin analogs eight weeks after 
transplantation. a Melanocyte in light tissue engineered skin analog; b Melanocyte in dark tissue engineered skin 
analog; c Keratinocyte in light tissue engineered skin analog; d Keratinocyte in dark tissue engineered skin 
analog. Melanocytes (M) are located in the basal layer of the epidermis on the basement membrane (dotted line). 
The adjacent dermis (D) can be identified by its collagen fibers. Melanin (white arrows) is clearly more 
pronounced in melanocytes (M) and keratinocytes (K) of the dark skin analog. Dendrites (black arrowheads) can 
be detected between cells. Scale bars 2 µm 
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Figure 6. Percentage of melanocytes in the basal layer of light and dark donor skin and of the corresponding 
tissue engineered skin analogs with melanocyte/keratinocyte ratios of 1:1, 1:5, and 1:10. 
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4.4 Analysis of blood and lymph vascularization patterns in tissue-engineered 
human dermo-epidermal skin analogs of different pigmentation 
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Abstract 
 
Purpose: Bioengineered dermo-epidermal skin analogs containing melanocytes represent a 
promising approach to cover large skin defects including restoration of the patient’s own skin 
color. So far, little is known about the development of blood and lymphatic vessels in 
pigmented skin analogs after transplantation. In this experimental study we analyzed the 
advancement and differences of host blood and lymphatic vessel ingrowth into light- and 
dark-pigmented human tissue-engineered skin analogs in a rat model.  
Methods: Keratinocytes, melanocytes, and fibroblasts from light- and dark-pigmented skin 
biopsies were isolated, cultured, and expanded. For each donor, melanocytes and 
keratinocytes were seeded in ratios of 1:1, 1:5, and 1:10 onto fibroblast-containing collagen 
gels. The skin analogs were subsequently transplanted onto full-thickness wounds of immuno-
incompetent rats and quantitatively analyzed for vascular and lymphatic vessel density after 8 
and 15 weeks. 
Results: The skin analogs revealed a significant difference in vascularization patterns between 
light- and dark-pigmented constructs after 8 weeks, with a higher amount of blood vessels in 
light compared to dark skin. In contrast, no obvious difference could be detected within the 
light- and dark-pigmented group when varying melanocyte/keratinocyte ratios were used. 
However, after 15 weeks, the afore-mentioned difference in blood vessel density between 
light and dark constructs could no longer be detected. Regarding lymphatic vessels, light and 
dark analogs showed similar vessel density after 8 and 15 weeks, whilst there were generally 
less lymphatic than blood vessels. 
Conclusion: These data suggest that, at least during early skin maturation, keratinocytes, 
melanocytes, and fibroblasts from different skin color types used to construct pigmented 
dermo-epidermal skin analogs have distinct influences on the host tissue after transplantation. 
We speculate that different VEGF expression patterns might be involved in this disparate 
revascularization pattern observed. 
Keywords:  Melanocytes - Melanocyte/keratinocyte ratio - Tissue-engineering - Light-/dark-
pigmented skin analog - Skin vascularization - Blood vessels - Lymphatic vessels - Rat model 
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Introduction 
 
The therapy of large full-thickness skin wounds, as e.g. in massive burns, is often 
difficult due to their complex systemic impact, but also due to lack of sufficient autologous 
donor skin. Theoretically, tissue-engineered full thickness skin analogs offer an important 
alternative to conventional autologous skin grafts. For several years, our laboratory has made 
substantial efforts to develop and characterize a tissue-engineered dermo-epidermal skin 
equivalent [1-5]. Most recently, we reconstituted pigmented dermo-epidermal skin analogs 
from different pigmentation types and achieved very satisfactory in vivo results restoring the 
patients’ native skin color [5]. This strategy holds promise for treatment of full-thickness skin 
defects as well as skin pigmentation disorders [6] in that the transplanted skin not only covers 
the defect, but also protects against ultraviolet radiation and provides the original skin color.  
It has been shown, that the skin of light- and dark-pigmented individuals exhibits 
numerous intrinsic physiological differences. Montagna et al. reported that the epidermis of 
black skin has more and larger singly distributed melanosomes in keratinocytes, and contains 
more cell layers in the stratum corneum than that of white skin [7]. The dermis of black skin 
demonstrates more collagen fibrils, glycoproteins, and larger, more numerous fibroblasts, as 
well as more apocrine and ecrine sweat glands than white skin [8]. Moreover, black skin 
shows a higher density of superficial (subepidermal) blood vessels as well as more numerous, 
larger lymphatic vessels, as well as more nerve fibers than white skin [8]. Black subjects’ skin 
is also less susceptible to cutaneous irritation induced by either chemicals or UV light and 
displays less erythema, less blood vessel reactivity, and cutaneous blood flow than white skin 
[9-12].  
However, little is known about the development of blood and lymphatic vessels in 
tissue-engineered pigmented skin analogs of different pigmentation types after transplantation 
and, in particular, there is no data regarding the aforementioned physiologic differences 
between black and white skin. 
In this experimental study, we investigated the differences of host blood and 
lymphatic vessel ingrowth into human tissue-engineered skin analogs derived from light- and 
dark-pigmented donor skin at 8 and 15 weeks after transplantation in a rat model. 
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Materials and Methods 
 
Human skin samples  
The investigation has been conducted according to Declaration of Helsinki principles and 
after acceptance of the Ethic Commission of the Canton Zurich. Children’s parents gave 
informed consent to use skin samples. The human foreskin samples were obtained from light 
and dark skin pigmentation types from patients 1 to 16 years of age. Human epidermal 
keratinocytes, melanocytes, and dermal fibroblasts were isolated from the skin samples. 
Tissue samples for histological examinations were embedded in paraffin, or in OCT 
compound (Sakura Finetek, Switzerland) and kept at -20 °C. 
 
Isolation and culturing of primary cells 
Keratinocytes and fibroblasts were isolated and cultured as described by Pontiggia et al. [4] 
and Biedermann et al. [13], melanocytes as specified in Böttcher-Haberzeth et al. [5].  
 
Preparation of tissue-engineered skin analogs 
Transwell cell culture plates in 6-well format containing inserts with 3.0 µm pore-size 
membranes (BD Falcon, Switzerland) were used to prepare skin analogs [3]. To reconstruct 
the dermal compartment, rat collagen type I was mixed with 0.2 ml neutralization buffer 
containing 0.15M NaOH and with 1x105 human dermal fibroblasts (passage 1-3). After 10 
min polymerization at room temperature and 45 min in an incubator at 37 °C, the dermal 
equivalents were grown for seven days in Dulbecco’s modified Eagle’s (DMEM) medium 
enriched with 10% FCS and Hepes (DMEM, Invitrogen, Switzerland). Subsequently, 5x105 
keratinocytes and melanocytes (passage 1-3) of the corresponding donor skin were seeded in 
different ratios (melanocyte/keratinocytes 1:1, 1:5, or 1:10) onto dermal equivalents. The skin 
analogs were cultured for one week in a 1:5 mix of melanocyte growth medium (Promocell, 
Germany) and keratinocyte medium (SFM, Invitrogen, Switzerland), and subsequently 
transplanted. 
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Transplantation of cultured dermo-epidermal skin analogs 
All animal studies have been approved by the local Committee for Experimental Animal 
Research (permission number: 76/2011). Immuno-deficient female nu/nu rats, 8 to 10 weeks 
old (Harlan Laboratories, Netherlands) were anesthetized as previously described [14-15]. 
Full-thickness skin wounds were created on the backs of the rats. Subsequently, custom made 
steel rings (diameter 2.6 cm) were sutured into the skin wounds using non-absorbable 
polyester sutures (Ethibond
®
, Ethicon, USA) and the skin analogs were sutured into those 
rings. Steel rings protected the skin analogs and prevented the closure of the wound by the 
surrounding rat skin. The transplants were then covered with a silicone foil (Silon-SES, BMS, 
USA), a polyurethane sponge (Ligasano, Ligamed, Austria), a cohesive conforming bandage 
(Sincohaft, Theo Frey AG, Switzerland), and tape as wound dressing. Dressing changes and 
photographic documentations were performed once per week. After 8 (N = 20) or 15 (N = 9) 
weeks the transplanted skin analogs were excised in toto and processed for paraffin- and cryo-
sections. 
 
Histological analysis  
Paraffin sections (5 µm) were stained with hematoxylin and eosin (Sigma, Switzerland) to 
assess the histological morphology. 
 
Immunohistochemical staining 
Immunofluorescence staining was performed as described in Böttcher-Haberzeth et al. [15-
16]. Double immunofluorescence stainings were performed to visualize rat blood and/or 
lymphatic vessels (CD31 [clone TDL-3A12, 1:50, BD Pharmingen, Switzerland], LYVE1 
[polyclonal, 1:200, Novus Biologicals, UK]), and human fibroblasts (CD90 [clone 5E10, 
1:50, Dianova, Germany]). The human control skin samples were double-stained for human 
CD31 [clone JC70A, 1:50, Dako, Switzerland], LYVE1 [clone ab10278, 1:200, Abcam, 
UK]), and human fibroblasts (CD90 [clone AS02, 1:50, Dianova, Germany]). 
 Pictures of immunofluorescence stainings were taken with a DXM1200F digital 
camera connected to a Nikon Eclipse TE2000-U inverted microscope. The device is equipped 
with Hoechst 33342-, FITC-, and TRITC-filter sets (Nikon AG, Switzerland; Software: Nikon 
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ACT-1 vers. 2.70). Images were processed with Photoshop 7.0 (Adobe Systems Inc, 
Germany). 
 
Rat blood and lymphatic vessel quantification 
Vessel profiles in skin analogs were counted on 6-8 μm thick cryo-sections double-stained for 
rat CD31/LYVE1 and human CD90. Five random fields at ×10 magnification were counted in 
three different sections of each skin analog after 8 or 15 weeks (n = 3-6). Vessel density was 
expressed as the average number of blood/lymphatic vessels from all fields counted in each 
skin analog. By double-staining for CD31 and LYVE1, it was possible to distinguish and 
separately quantify LYVE1-CD31+ blood vessels and LYVE1+CD31+ lymph vessels. All 
results are reported as mean ± standard deviation (SD). Statistical analysis was performed 
with GraphPad Prism 4.0 (Graph Pad software, La Jolla, CA, USA). Comparison between two 
groups was performed using the unpaired Student’s t test. Results were considered significant 
with a P < 0.05. 
 
Results 
 
Analysis of normal human and rat skin 
Native human and rat skin show specific differences, as demonstrated by a hematoxylin and 
eosin staining (Fig. 1a, b). In comparison to human foreskin (Fig. 1a), rat back skin (Fig. 1b) 
is composed of less epidermal layers. It also contains hair follicles and sebaceous glands 
throughout the dermis. To show the presence of human fibroblasts in the dermal compartment 
of human skin, we used a human specific anti-CD90 antibody, which does not stain rat 
fibroblasts (green, Fig. 1c, d). Human and rat blood vessels, specifically labeled with the anti-
human or -rat CD31 antibody (red, Fig 1 c, d), were very abundant in the dermis of both 
species. 
To distinguish lymphatic vessels from blood vessels in the skin, we used an antibody 
to stain LYVE1, a lymphatic endothelium-specific marker (green, Fig. 1e-f). Both human and 
rat blood vessels were LYVE1-negative, however, lymphatic vessels also showed a faint 
CD31-staining.   
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Macroscopic appearance and epidermal structure of human light- and dark-pigmented 
skin analogs 
Eight weeks after transplantation the reconstructed human skin analogs from light- and dark-
pigmented donor skin showed a strong resemblance to the donor skin regarding color and 
structure, independent of which melanocyte/keratinocyte ratio (1:1, 1:5, 1:10) was used (data 
not shown). Pigmentation was homogenous throughout the entire transplant of all specimens. 
 Also, 15 weeks after transplantation, light- and dark-pigmented skin analogs prepared 
with a melanocyte/keratinocyte ratio of 1:5 showed macroscopically a light and dark aspect 
with homogenous pigmentation (Fig. 2a, b). Microscopically, both skin analogs showed a 
stratified and cornified epidermis on a cellularized neodermis (Fig. 2a, b). However, a 
noticeable difference between the two analogs was the strongly pigmented basal layer of the 
dark skin analog (Fig. 2b). Moreover, skin appendages and rete ridges were absent in all 
engineered skin samples. 
 
Blood vessel patterns of transplanted human tissue-engineered skin analogs 
Eight weeks post-transplantation, light- and dark-pigmented skin analogs prepared with 
different ratios of melanocytes/keratinocytes (1:1, 1:5, 1:10) were excised and analyzed. The 
human dermal compartment was delineated by an anti-human CD90-staining (green, Fig. 3). 
The ingrowth of host blood vessels into the human transplants was analyzed using a staining 
against rat-CD31 (red, Fig. 3) and thereafter quantified (Fig. 4). 
After eight weeks, light- and dark-pigmented skin analogs were entirely vascularized 
showing blood vessels throughout the human CD90-stained dermal compartment with a dense 
superficial vascular network underneath the epidermis (Fig. 3). The quantification revealed 
that the light-pigmented group contained a significantly higher number of blood vessels than 
the dark-pigmented group (Fig. 4a). However, the overall blood vessel density within the 
light-pigmented group did not show any obvious differences when varying 
melanocyte/keratinocyte ratios were used: 50 ± 14 vessels/mm
2
 (1:1 ratio); 45 ± 8 
vessels/mm
2
 (1:5 ratio); 51 ± 8 vessels/mm
2
 (1:10 ratio). A similar observation was made 
within the dark-pigmented group: 31 ± 6 vessels/mm
2
 (1:1 ratio); 34 ± 8 vessels/mm
2
 (1:5 
ratio); 34 ± 11 vessels/mm
2
 (1:10 ratio) (Fig. 4a).  
After 15 weeks, significantly fewer blood vessels were detected in both light- and 
dark-pigmented skin analogs (melanocyte/keratinocyte ratio 1:5). The light-pigmented 
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analogs contained 23 ± 10 vessels/mm
2
 and the dark-pigmented analogs 25 ± 6 vessels/mm
2
 
(Fig. 5a, b; Fig. 6a).  
 
Lymphatic vessel patterns of transplanted human tissue-engineered skin analogs 
Eight weeks after transplantation, the human skin analogs were analyzed for the presence of 
lymphatic, LYVE1-positive, vessels in the human CD90-stained neodermis and quantified 
(Fig. 4b). The lymphatic vessels were randomly distributed throughout the human dermal 
compartment, but were rare in close proximity to the dermo-epidermal junction. They 
displayed an irregular shape and were slightly larger in diameter than blood capillaries. 
Moreover, ingrowth was established five weeks post-transplantation as compared to blood 
vessel networks, which were already completely established after three weeks in vivo (data 
not shown).  
After eight weeks, we did not detect any statistically significant difference in the 
lymphatic vessel densities between varying melanocyte/keratinocyte ratios of light- ((6 ± 3 
vessels/mm
2
 (1:1 ratio); 7 ± 3 vessels/mm
2
 (1:5 ratio);   9 ± 3 vessels/mm
2
 (1:10 ratio)), and 
dark-pigmented group ((9 ± 3 vessels/mm
2
 (1:1 ratio); 9 ± 5 vessels/mm
2
 (1:5 ratio); 8 ± 4 
vessels/mm
2
 (1:10 ratio). Of note, they occurred at a much lower density as compared to 
blood vessels (Fig. 4b).  
The number of lymphatic vessels did not change after 15 weeks post-transplantation 
and was comparable to the amount at 8 weeks in both light- (7 ± 3 vessels/mm
2
) and dark-
pigmented skin analogs (9 ± 4 vessels/mm
2
) (both 1:5 ratio) (Fig. 5c, d; Fig. 6b). 
 
Discussion 
To the best of our knowledge, this is the first study investigating the blood and lymphatic 
vessel patterns in differentially pigmented human tissue-engineered skin analogs at 8 and 15 
weeks after transplantation. In particular, we analyzed quantitative differences in 
revascularization patterns between light- and dark-pigmented skin analogs. Overall our study 
demonstrates distinctly disparate blood vessel densities in the early wound healing stages at 8 
weeks post-transplantation between the light- and the dark-pigmented groups. Interestingly, 
this clear differences can no longer be observed at a later stage, namely at 15 weeks post-
transplantation. Of note, these differences can not be seen regarding lymph vessel ingrowth. 
Some aspects deserve to be addressed in more detail. 
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The fact that we observe a disparate vascularization pattern between light- and dark-
pigmented constructs eight weeks after transplantation, with a significantly higher amount of 
blood vessels in the light- compared to the dark-pigmented skin analog group, is clearly 
surprising. Little is known about differences concerning blood and/or lymphatic vessel 
densities in light and dark-pigmented human skin. What has already been described is that the 
facial skin of dark-pigmented individuals contains a higher density of superficial blood 
vessels than the facial skin of light-pigmented persons [8].  Of note, dark skin is less 
susceptible to different chemical irritants, most probably due to decreased blood vessel 
reactivity, and therefore less cutaneous blood flow [9-12]. Our results from 8 weeks after 
transplantation do not demonstrate a vascularization pattern reflecting this distinct 
physiological morphology but rather show the opposite. We hypothesize, that this time point 
might be too early for skin analogs to show distinct differences as seen in a physiological, i.e. 
homeostatic situation. Another explanation could be that the differences between dark and 
light facial skin reported by Montagna et al. [8], might simply not be present in light and dark 
foreskins as used in our study, because these cells exhibit diverse angiogenic characteristics. 
Indeed, when analyzing native light and dark foreskin samples, we were not able to detect any 
apparent differences regarding blood vessels or VEGFA expression patterns (data not shown). 
Nonetheless, the fact that we observe significant differences in the early, i.e. probably not yet 
homeostatic, vascular pattern between light- and dark-pigmented skin analogs, suggests that 
intrinsic signals stemming from keratinocytes, melanocytes, or fibroblasts must be responsible 
for this transient phenomenon. 
Interestingly, 15 weeks post-transplantation no more differences could be detected in 
the number of vessels present light and dark grafts. We propose the following interpretation 
for this change from 8 to 15 weeks. Shortly after transplantation, skin tissue demands to be 
quickly revascularized to ensure cell survival and adequate integration of the transplant into 
the host tissue [17-18]. Later, as the graft matures and reaches the remodeling stage, the 
initially needed, but now redundant vascular networks are reduced [19-20].  
Of note, although we do notice the described, temporary difference in the 
vascularization dynamics, all transplants exhibit an apparently competent capillary network 
within the dermal compartment, ensuring survival and, presumably, also supporting 
maturation of the dermo-epidermal skin analogs. 
Regarding lymphatic vessels, we observe an equal density at 8 and 15 weeks after 
transplantation. However, their ingrowth occurs later and the number of lymphatic vessels is 
clearly less compared to blood vessels. Interestingly, an abundant rat blood capillary network 
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can be identified in the dermal compartment as early as three weeks post transplantation, 
whereas a beginning lymphatic vessel ingrowth in our skin analogs was seen only five weeks 
after transplantation (data not shown). It is reasonable to argue that the establishment of a 
rapid vascular supply within the transplanted skin has the highest priority with regard to 
immediate graft take and long-term survival, and therefore occurs earlier than lymphatic 
vessel ingrowth. Of note, Nogami et al. [21] followed the recovery of lymphatic vessels in rat 
skin incision wounds up to 12 weeks and found that lymphatic vessels were not present in the 
wound area, but only in the surrounding intact tissue. In contrast, we observed that lymphatic 
vessels regenerated ubiquitously and abundantly in the dermis of our skin analogs already five 
weeks after transplantation. Furthermore, previous reports showed that lymphatic 
regeneration across scar tissues is severely impaired and that fibrosis in a wound can be 
directly responsible for lymphedema formation due to reduced lymphatic endothelial cell 
proliferation and abnormal lymphatic microarchitecture [22-23]. In light of the above, our 
findings are particularly important with regard to our planned clinical application of 
laboratory engineered skin substitutes. It appears tenable that a competent lymphatic vessel 
supply will also develop when our skin substitutes are autologously transplanted onto human 
patients.  
In summary and conclusion, this appears to be the first article demonstrating that 
differently pigmented human tissue-engineered dermo-epidermal skin analogs show a near 
physiological ingrowth of both blood and lymphatic in a rat model. Further, our results 
suggest that different cells, especially keratinocytes, melanocytes, and fibroblasts of light- and 
dark-pigmented skin analogs seem to orchestrate temporarily disparate vascularization 
patterns. It appears likely that favorable blood and lymphatic vessels ingrowth dynamics take 
place when autologous tissue-engineered skin analogs are transplanted onto human patients. 
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Figures and Tables 
 
 
 Figure 1. Evaluation of normal human foreskin and rat back skin and the expression of blood- and lymphatic-
specific markers. a, b Hematoxylin and eosin staining showing a comparison of normal human versus rat skin; 
rat skin reveals less layers in the epidermis and abundant hair follicles in the dermis. c, d Immunofluorescence 
double staining of human and rat skin with antibodies against human CD90 (staining of human dermal 
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compartment, green) and against human and rat CD31 (staining of blood vessels, red). e, f Immunofluorescence 
double staining of human and rat skin with antibodies against human and rat LYVE1 (lymphatic vessels, green) 
and against human and rat CD31 (blood vessels, red), distinguishing human and rat lymphatic vessels (white 
arrowheads) from blood vessels (white arrows). LYVE1-positive lymphatic vessels are faintly positive for CD31 
too; however, blood vessels are LYVE1 negative. Thus, LYVE1 was used as a lymphatic-specific marker for all 
further experiments. Cell nuclei are stained with Hoechst (blue). Scale bars 100 μm. 
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Figure 2. Tissue-engineered human skin analogs constructed with keratinocytes and melanocytes (1:5 ratio) 
derived from light or dark donor skin 15 weeks after transplantation. Macroscopic aspect and hematoxylin and 
eosin staining of light- (a) and dark-pigmented (b) skin analogs. The constructs both demonstrate a macroscopic 
and microscopic appearance that, except for the absence of rete ridges and skin appendages, closely resemble 
normal human light- and dark-pigmented skin. Scale bars 100 μm 
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Figure 3. Host vascularization of light- and dark-pigmented skin analogs (melanocyte/keratinocyte ratio 1:1, 1:5, 
1:10) 8 weeks after transplantation. a, c, e Rat blood vessels of light skin are stained with an antibody against rat 
CD31 (red). b, d, f Rat blood vessels of dark skin are stained with an antibody against rat CD31 (red). Human 
dermal compartment is delineated by an anti-human CD90 staining (green), and cell nuclei with Hoechst (blue). 
Light- and dark-pigmented skin analogs show ubiquitous and abundant blood vessels throughout the human 
CD90-stained neodermis. Scale bars 100 μm 
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Figure 4. The density of rat blood and lymphatic vessels in light- and dark-pigmented skin analogs 
(melanocyte/keratinocyte ratio 1:1, 1:5, 1:10) 8 weeks after transplantation. a Blood vessel (CD31) density of 
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light- (white bars) and dark-pigmented analogs (black bars). Note a significantly higher number of blood vessels 
in the light- than the dark-pigmented group. b Lymphatic vessel (LYVE1) density of light- (white bars) and 
dark-pigmented analogs (black bars). Of note, lymphatic vessel ingrowth occurred at a much lower density as 
compared to blood vessels, regardless of the pigmentation pattern. Table shows values as the mean (± SD) 
number of rat blood (a)/lymphatic (b) vessels quantified per mm2. N = 3 or 4 for each group 
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Figure 4. The density of rat blood and lymphatic vessels in light- and dark-pigmented skin analogs 
(melanocyte/keratinocyte ratio 1:1, 1:5, 1:10) 8 weeks after transplantation. a Blood vessel (CD31) density of 
light- (white bars) and dark-pigmented analogs (black bars). Note a significantly higher number of blood vessels 
in the light- than the dark-pigmented group. b Lymphatic vessel (LYVE1) density of light- (white bars) and 
dark-pigmented analogs (black bars). Of note, lymphatic vessel ingrowth occurred at a much lower density as 
compared to blood vessels, regardless of the pigmentation pattern. Table shows values as the mean (± SD) 
number of rat blood (a)/lymphatic (b) vessels quantified per mm
2
. N = 3 or 4 for each group 
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Figure 5. Host blood and lymphatic vessels in light and dark skin analogs (melanocyte/keratinocyte ratio 1:5) 15 
weeks after transplantation. Rat blood vessels of light- (a) and dark-pigmented (b) skin analogs are stained with 
an antibody against rat CD31 (red). Differentially pigmented skin analogs show similar blood vessel patterns 
throughout the human CD90-stained neodermis (green). Lymphatic vessels of light (c) and dark (d) skin analogs 
stained with LYVE1 (green) appear at much lower density in human CD90-dermal compartment (red) as 
compared to blood vessels. Cell nuclei are stained with Hoechst (blue). Scale bars 100 μm 
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Figure 6. The density of rat blood and lymphatic vessels in light- and dark-pigmented skin analogs (1:5 ratio) 15 
weeks after transplantation. a Patterns of blood vessel (CD31) in light (white bars) and dark analogs (black bars) 
do not reveal any statistically significant difference. b Lymphatic vessel (LYVE1) patterns of light (white bars) 
and dark analogs (black bars) are comparable and appear at lower density than those of blood vessels. Table 
show values as the mean (± SD) number of rat blood (a)/lymphatic (b) vessels quantified per mm
2
. N = 3 or 4 for 
each group 
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4.5 Tissue-engineered dermo-epidermal skin analogs exhibit de novo 
formation of a near natural neurovascular link 10 weeks after transplantation 
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Abstract 
 
Purpose: Human autologous tissue-engineered skin grafts are a promising way to cover skin 
defects. Clearly, it is mandatory to study essential biological dynamics after transplantation, 
including reinnervation. Previously, we have already shown that human tissue-engineered 
skin analogs are reinnervated by host nerve fibers as early as 8 weeks after transplantation. In 
this study, we tested the hypothesis that there is a de novo formation of a “classical” 
neurovascular link in tissue-engineered and then transplanted skin substitutes. 
Methods: Keratinocytes, melanocytes, and fibroblasts were isolated from human skin 
biopsies. After expansion in culture, keratinocytes and melanocytes were seeded on dermal 
fibroblast-containing collagen type I hydrogels. These human tissue-engineered dermo-
epidermal skin analogs were transplanted onto full-thickness skin wounds on the back of 
immuno-incompetent rats. Grafts were analyzed after 3 and 10 weeks. Histological sections 
were examined with regard to the ingrowth pattern of myelinated and unmyelinated nerve 
fibers into the skin analogs using markers such as PGP9.5, NF-200, and NF-160. Blood 
vessels were identified with CD31, lymphatic vessels with Lyve1. In particular, we focused 
on alignment patterns between nerve fibers and either blood and/or lymphatic vessels with 
regard to neurovascular link formation. 
Results: Three weeks after transplantation, blood vessels, but no nerve fibers or lymphatic 
vessels could be observed. 10 weeks after transplantation, we could detect an ingrowth of 
myelinated and unmyelinated nerve fibers into the skin analogs. Nerve fibers were found in 
close proximity to CD31-positive blood vessels, but not alongside Lyve1-positive lymphatic 
vessels. 
Conclusion: These data suggest that host-derived innervation of tissue-engineered dermo-
epidermal skin analogs is initiated by and guided alongside blood vessels present early post-
transplantation. This observation is consistent with the concept of a cross talk between 
neurovascular structures, known as the neurovascular link. 
Keywords: Human skin analog – Tissue engineering – Blood vessels - Nerve fibers - 
Innervation – Neurovascular link – Lymphatic vessels  
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Introduction  
 
Loss of full-thickness skin is unequivocally accompanied by loss of skin sensibility. Although 
there is a large spectrum of surgical methods to cover skin defects (transplantation of full-
thickness skin, split-thickness skin, biosynthetic skin substitutes, cultured epithelial cells, and 
combinations thereof), initially there is no sensibility present as nerve fibers migrate only 
slowly from the wound bed into the transplant [1-6]. Little is known about the chain of events 
leading to reinnervation, especially since skin appendages such as hair follicles and sweat 
glands known to provide guidance cues for nerve fibers are also missing [7, 8]. 
 It is well documented that blood vessels commonly reside alongside peripheral nerves 
[9]. Interestingly, nerves and vessels influence one another with regard to patterning, 
branching, development, and regeneration after injury [10-12]. For example, smooth muscle 
cells surrounding blood vessels secret artemin, a glial cell-derived neurotrophic factor 
(GDNF), which binds the Ret/GFRα3 receptor of neurons and so guides the nerve fiber to the 
target organ [13]. In addition, it appears that vascular endothelial cell derived VEGF-A can 
control axon cone growth of neurons and guide nerve sprouting along arterial networks via 
VEGF-receptor 2 signaling [14, 15]. 
 We have recently shown that tissue engineered and then transplanted dermo-epidermal 
skin analogs are distinctly vascularized by host blood capillaries after three weeks [16]. 
However, the ingrowth of nerve fibers into the transplant was observed only eight weeks after 
transplantation.  
 We now investigated if the nerve fibers are attracted by and grow alongside the blood 
vessel network into the transplanted skin analogs and if there is also a topographical 
relationship between nerve fibers and the lymphatic vessels.  
 
Materials and Methods 
 
Human skin samples 
This experimental study was performed in accordance with the Declaration of Helsinki 
Principles and after permission by the Ethic Committee of the Canton Zurich. Informed 
consent was given by parents and/or patients. Human foreskins or skin samples from scalp or 
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abdomen were obtained from patients aged between 1 and 18 years. The skin biopsies were 
used for isolation of human epidermal keratinocytes, melanocytes, and dermal fibroblasts. 
 
Isolation and culturing of primary cells 
Keratinocytes and fibroblasts were isolated and cultured as described by Biedermann et al. 
[17]. Melanocytes were isolated and kept in culture as specified in Böttcher-Haberzeth et al. 
[18]. 
 
Preparation of dermo-epidermal skin analogs 
Skin analogs were prepared in six well cell culture inserts with 3.0 µm pore size membranes 
in a transwell system (BD Falcon, Switzerland) [19]. To generate the dermal compartment, 
the membranes were covered with collagen type I hydrogels containing human dermal 
fibroblasts. Rat tail collagen type I (0.7 ml) (BD Biosciences, Switzerland) was mixed with 
0.2 ml chilled neutralization buffer containing 0.15 M NaOH and 1x10
5
 fibroblasts (passage 
1). After polymerization (10 min at room temperature and 20 min at 37 ºC), the dermal 
equivalents were cultured in DMEM containing 10 % FCS for five days. Subsequently, 
keratinocytes and melanocytes (ratio 5:1, passage 1-3) were seeded onto each dermal 
equivalent at a density of 4x10
5
 cells. The skin analogs were cultured in SFM (Invitrogen, 
Switzerland) for one week before transplantation. The medium was changed every second 
day. 
 
Transplantation of cultured dermo-epidermal skin analogs 
The surgical procedure was approved by the local committee for Experimental Animal 
Research (permission numbers 65/2009, 76/2011). Immuno-incompetent female nu/nu rats, 
8–10 weeks old (Harlan Laboratories, Netherlands) were anesthetized prior to operation as 
previously described [20, 21]. To protect the skin analogs and to prevent wound closure from 
surrounding rat skin, surgical steel rings (diameter 2.6 cm) were sutured into full-thickness 
skin defects made on the backs of the rats, using non-absorbable polyester sutures (Ethibond
®
, 
Ethicon, USA). The transplants were then covered with a silicone foil (Silon-SES, BMS, 
USA), a polyurethane sponge (Ligasano, Ligamed, Austria), and a tape as wound dressing. 
Dressing changes and photographic documentations were performed on a weekly basis.  
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Analysis of the transplants 
 After 3 or 10 weeks, animals were killed using CO2. Transplants and rat control skin were 
excised and embedded in OCT compound (Sakura Finetek/Digitana AG, Switzerland). 
Cryosections were stained with haematoxylin and eosin (Sigma, USA), and mounted within 
Eukitt (Fluka, Switzerland) for histological analysis. Double immunofluorescence stainings 
were performed to visualize myelinated and/or unmyelinated rat nerve fibers [ubiquitin 
carboxyl-terminal hydrolase L1 (PGP9.5, clone 13C4/J3C4, 1:50, Abcam, Germany)], 200 
kDa neurofilament (NF200, clone NF01, 1:50, Abcam, Germany), 160 kDa neurofilament 
(NF160, clone NN18, 1:50, Sigma-Aldrich, Germany), rat vascular endothelial cells [CD31 
(clone TDL-3A12, 1:50, BD Pharmingen, Switzerland)], rat lymphatic endothelial cells 
[Lyve1 (polyclonal, 1:200, Novus Biologicals, UK)], vascular basement membrane protein 
[Laminin1+2 (clone ab7463, 1:500, Abcam, Germany)], and human fibroblasts [CD90 (clone 
AS02, 1:50, Dianova, Germany)]. Cryosections were fixed and permeabilized in 
acetone/methanol for 5 min at -20 ºC, air dried, and washed 3x in phosphate-buffered saline 
(PBS, Invitrogen, Switzerland). Thereafter, sections were blocked in PBS containing 2 % 
BSA (Sigma, Switzerland) for 30 min. Incubation with the diluted first antibody was 
performed in blocking buffer for 1 h at room temperature. Afterwards, slides were washed 
three times for 5 min in PBS and blocked for additional 15 min. To visualize the primary 
antibody, FITC-conjugated polyclonal goat F(ab´)2 fragments directed to mouse 
immunoglobulins (Dako, Switzerland) were added to the sections. Slides were washed three 
times for 5 min in PBS and blocked for additional 15 min. For double immunofluorescence, 
NF and CD31 primary antibodies were prelabeled with Alexa 555-conjugated polyclonal goat 
F(ab´)2 fragments according to the manufacturer's instructions (Zenon Mouse IgG Labeling 
Kit, Molecular Probes/Invitrogen, Switzerland) and added to the sections. Finally, the slides 
were incubated for 5 min in PBS containing 1 μg/ml Hoechst 33342 (Sigma, Switzerland), 
washed twice for 5 min in PBS, and mounted with Dako mounting solution (Dako, 
Switzerland). 
Pictures of immunofluorescence stainings were taken with a DXM1200F digital camera 
connected to a Nikon Eclipse TE2000-U inverted microscope. The device is equipped with 
Hoechst 33342, FITC, and TRITC filter sets (Nikon AG, Switzerland; Software: Nikon ACT-
1 vers. 2.70). Images were processed with Photoshop 10.0 (Adobe Systems Inc., Germany). 
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Results 
 
Expression of blood- and lymphatic endothelial markers in normal rat skin 
Native rat skin from the back was tested for blood- and lymphatic endothelial marker 
expression (Fig. 1). Skin samples were double-stained for endothelial cells (CD31, red, Fig. 
1a, b) and basement membrane markers (Laminin1+2, green, Fig. 1a). In contrast to the CD31 
and Laminin1+2 positive blood vessels (white arrows, Fig. 1a), the lymphatic vessels were 
faintly CD31 positive and showed no staining for Laminin1+2 (white arrowheads, Fig. 1a). 
 To further confirm the identity of blood and lymphatic vessels, anti-CD31 staining 
was combined with LYVE1, which is a marker for lymphatic endothelial cells. As depicted in 
Fig. 1b, the blood vessels were CD31-positive but LYVE1-negative (white arrowheads), 
whereas the lymphatic vessels showed a faint CD31-staining and strong LYVE1-expression 
(white arrows).  
 
Innervation and vascularization pattern of normal rat skin 
Native rat skin from the back was co-stained for nerve fiber marker expression using 
antibodies against NF200 (green), and blood (CD31, red, Fig. 1c) or lymphatic vessels 
(LYVE1, red; Fig. 1d). We observed that nerve fibers are located in close proximity to blood 
vessels (white arrows, Fig. 1c), whereas no co-localization of nerve fibers with lymphatic 
vessels was noted (Fig. 1d). 
 
Innervation and vascularization pattern of transplanted human tissue engineered skin 
analogs 
After excision of the human tissue engineered skin analogs ten weeks after transplantation, 
anti rat-CD31 staining showed an abundant capillary network throughout the dermal 
compartment delineated with a CD90-staining of human fibroblasts (Fig. 2a). In contrast to 
blood vessels, the LYVE1-positive lymphatic vessels appeared in lower numbers, were 
irregular in shape, and larger in diameter as compared to blood vessels (Fig. 2b). Host 
myelinated and unmyelinated rat nerve fibers (green) were detected in the human dermal 
compartment (CD90, red) by staining for NF200 and PGP9.5 (Fig. 2c, d).  
 As a control, the presence of established rat blood and lymphatic vessel networks was 
investigated three weeks after transplantation. Blood vessels (CD31, Fig. 2e) occurred 
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abundantly in the human dermal compartment (CD90, green), whereas no lymphatic vessels 
were detected in the human dermis (Fig. 2f). The earliest ingrowth of lymphatic capillaries 
into the skin analogs appeared five weeks after transplantation (data not shown). 
 
Pattern of nerve fibers and blood vessels in human tissue engineered skin analogs 
Ten weeks post-transplantation, host blood vessels were visualized in the human dermal 
compartment by anti-CD31 (red) staining. Myelinated nerve fibers were visualized by 
staining for NF200 (Fig. 3a, b) and NF160 (Fig. 3c, d), while unmyelinated nerve fibers were 
identified by anti-PGP9.5 staining (Fig. 3e, f). In almost all sections, rat nerve fibers were 
aligned along blood vessels (white arrows).  
 
Pattern of nerve fibers and lymphatic vessels in human tissue engineered skin analogs 
Ten weeks after transplantation, sections with lymphatic vessels staining positive for LYVE1 
were co-stained with nerve fiber markers such as NF200 (Fig. 4a, b), NF160 (Fig. 4c, d), and 
PGP9.5 (Fig. 4e, f). We observed lymphatic vessels in vicinity to nerve fibers, but we did not 
detect any alignment of the structures. 
 
Discussion 
 
This is an experimental study investigating the question whether host-derived innervation of 
previously transplanted human tissue engineered skin analogs is guided alongside host blood 
or lymphatic vessels. In general, our findings demonstrate a clear cut topographical 
relationship between blood vessels and nerve fibers, but not between lymphatic vessels and 
nerve fibers. Thus, our hypothesis that a de novo formation of a typical neurovascular link 
occurs in tissue engineered skin grafts after transplantation, proves true.   
 The dynamics of host blood vessels, lymphatic vessels, and nerve fibers populating 
transplanted human tissue engineered skin analogs are fundamentally different. We have 
shown previously that an established vascular network can be detected as early as three weeks 
post-transplantation while innervation of the dermal compartment is present only eight weeks 
post-transplantation [16]. Certainly, early vascularization of a transplanted skin analog by 
capillaries and larger blood vessels is crucial to ensure sustained graft take and long-term 
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survival and has therefore the highest physiological “priority” regarding the establishment of 
host structures within the transplanted tissue. In contrast, lymphatic vessels and nerve fibers 
are not indispensable for graft survival during the early stage after transplantation. Therefore, 
we decided to investigate the skin analogs 10 weeks after transplantation in order to detect 
eventual topographical relationships between blood or lymphatic vessels and nerves fibers. 
 It has been described previously that vascular and nervous networks develop in close 
proximity during development, reflecting their mutual dependency [22]. To enable an 
alignment, the structures need to communicate with each other through signals, a molecular 
exchange called “neurovascular crosstalk” [23]. Herby, several guidance molecules, such as 
artemin, VEGF, or endothelin-3, are secreted from blood vessels and attract nerve fibers along 
a certain ligand-gradient to establish innervation [12, 14, 15]. On the other hand, guidance 
signals are also secreted from the peripheral nervous system. For instance, VEGF leads to an 
attraction and branching of blood vessels as well as to arterial differentiation in the skin [24].  
Based on the above mentioned evidence, we developed our hypothesis that initially non-
vascularized and non-innervated laboratory grown skin substitutes develop a kind of 
physiological perfusion and innervation system over time, a newly formed neurovascular link. 
Although we did not perform the extremely demanding molecular pathway studies that the 
aforementioned ground breaking papers described [12, 14, 15, 22-24], we could convincingly 
demonstrate that 10 weeks after transplantation a de novo formed neurovascular link was 
present in the dermal compartment of the perfectly well engrafted skin substitutes. In all 
specimens examined, there was a typical alignment between blood vessels and nerve fibers as 
seen in normal neurovascular links. On the other hand, such a relationship could not be seen 
between lymphatic vessels and blood vessels or nerve fibers. 
 Clearly, the presence of neurovascular links also means that neurovascular crosstalk 
must have occurred [23]. In our setting, the initiators of this neurovascular communication 
have certainly been blood vessels as they are present in these transplants much earlier than 
nerve fibers. Also it is a tenable assumption that the vascular network within the grafted area 
received an intrinsic innervation during the neurovascular link development enabling blood 
vessels to react to synaptically passed signals that cause vasoconstriction and vasodilatation 
[25, 26]. It might be interesting to look at this issue in a follow-up study. 
 Although, our dermo-epidermal skin analogs do not contain only adnexal structures 
such as hair follicles or sweat glands, a few considerations regarding the potential impact of 
skin appendages in the context of innervation are worth being made. It has been proposed that 
integrating such appendages into tissue engineered skin substitutes could enforce the ingrowth 
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of nerves, as glands and hair follicles are very well vascularized and innervated [8, 27-29]. It 
has also been described that the incorporation of Schwann cells or the use of modified 
scaffolds could promote the innervation of skin analogs [30, 31]. Possibly, the integration of 
human hair follicles and sweat glands could, beside being a revolutionary step towards 
engineering normal skin, also improve the velocity and quality of reinnervation of our tissue 
engineered dermo-epidermal skin analogs. 
 Finally, we analyzed the dynamics of lymphatic vessel ingrowth into the transplants. 
After 10 weeks, we could detect lymphatic vessels and nerve fibers in the dermal 
compartment. Although lymphatic vessels were found in vicinity of nerve fibers, they did not 
show an alignment pattern as seen in the neurovascular link.  
 In conclusion, our data suggest that a de novo formation of a close to natural 
neurovascular link occurs over a time span of 10 weeks after transplantation of tissue 
engineered skin analogs that are initially devoid of any vascular and neural elements. 
 The fact that there is ingrowth of both, normal neurovascular structures as well as 
lymphatic vessels into engineered skin grafts has favorable clinical implications in view of the 
envisioned application of such grafts in human patients. 
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Figures and Tables 
 
 
Figure 1. Evaluation of blood, lymphatic vessel, and nerve fiber distribution in normal rat back skin. a Staining 
of normal rat skin for CD31 (red) and basement membrane staining for Lam1+2 (green). Blood vessels show a 
double staining with CD31 and Laminin1+2 (white arrows); structures staining for CD31 only show lymphatic 
vessels (white arrowheads). b Staining of normal rat skin with LYVE1 (green) and CD31 (red). Lymphatic 
vessels display a double staining with LYVE1 and CD31 (white arrows); structures staining for CD31 only show 
blood vessels (white arrowheads).c Staining of blood vessels with CD31 (red) and of nerve fibers with NF200 
(green). An alignment between blood vessels and nerve fibers can be detected (white arrows). d Staining of 
lymphatic vessels with LYVE1 (red) and of nerve fibers with NF200 (green). No co-localization between 
lymphatic vessels and nerve fibers can be noted (white arrows). Cell nuclei are stained with Hoechst (blue). 
Scale bar for all panels 50 µm. 
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Figure 2. Evaluation of host blood and lymphatic vessel distribution as well as host innervation in human tissue 
engineered skin analogs 10 weks after transplantation. a Staining of rat blood vessels with CD31 (red) and of 
human fibroblasts with CD90 (green). b Staining of rat lymphatic vessels with LYVE1 (red) and of human 
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fibroblasts with CD90 (green). c, d Staining of rat nerve fibers with NF200 and PGP9.5 (green), human dermal 
fibroblasts are stained with CD90 (red). e Staining of rat blood vessels with CD31 (red) and of human 
fibroblasts with CD90 (green) 3 weeks after transplantation. f Staining of rat lymphatic vessels with LYVE1 
(red) and of human fibroblasts with CD90 (green) 3 weeks after transplantation. Cell nuclei are stained with 
Hoechst (blue). The human dermal compartment is marked by a two-sided arrow, the basement membrane is 
delineated by a dotted line, the lower border of the human compartment by a dashed line. Scale bar for all panels 
50 m. 
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Figure 3. Evaluation of host innervation 
relating to host vascularization in human 
tissue engineered skin analogs 10 weeks 
after transplantation. a-f Staining of rat 
blood vessels with CD31 (red) and of rat 
nerve fibers with NF200, NF160, and 
PGP9.5 (green). Cell nuclei are stained 
with Hoechst (blue). The dermal 
compartment is marked by a two-sided 
arrow; the basement membrane is 
delineated by a dotted line. An alignment 
between host nerve fibers and blood 
vessels can be seen in several areas 
(arrows). Scale bar for all panels 50 m. 
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Figure 4. Evaluation of host innervation 
relating to host lymphatic vessels in 
human tissue engineered skin analogs 10 
weeks after transplantation. a-f Staining 
of rat lymphatic vessels with LYVE1 
(red) and of rat nerve fibers with NF200, 
NF160, and PGP9.5 (green). Cell nuclei 
are stained with Hoechst (blue). The 
dermal compartment is marked by a two-
sided arrow; the basement membrane is 
delineated by a dotted line. A vicinity of 
lymphatic vessels and nerve fibers can 
be seen, but no alignment. Scale bar for 
all panels 50 m. 
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5. CONCLUSIONS 
Tissue-engineered dermo-epidermal skin grafts prevascularized with adipose-derived 
cells (chapter 4.1) 
The absence of perfusable vascular networks still remains one of the central hurdles in the 
field of skin tissue-engineering. In this study I successfully developed prevascularized dermo-
epidermal skin substitutes (vascDESS) for clinical application using human adipose-derived 
cells. For this I applied the stromal vascular fraction (SVF) derived from adipose tissue 
containing endothelial and mesenchymal cells, which are able to spontaneously develop into a 
mature and functional microvascular network in vitro. Of note, the SVF is relatively abundant 
and accessible in comparison to other adult autologous cell sources and can be used 
intraoperatively after tissue harvest, without in vitro expansion. 
The peculiarity of the endothelial cell fraction of the SVF is, however, that it can only 
be maintained in a suitable 3D culture system, whereas it is rapidly lost on cell culture plastic 
(in 2D culture). I managed to establish appropriate in vitro conditions by integrating the SVF 
into a previously developed tissue-engineered, hydrogel-based, dermo-epidermal skin graft. 
The de novo microvascular plexus, developing under these circumstances, demonstrated a 
great similarity to normal human capillaries, exhibiting a lumen, pericyte coverage, and 
organotypic microstructures, such as a basal lamina, "peg-and-socket" junctions, pseudopodia, 
caveolae, pinocytotic vesicles, and complex intercellular junctions.  
Using the in vitro prevascularization approach, I was able to considerably accelerate 
the onset of blood perfusion in the skin substitutes after transplantation, which resulted in 
several positive effects in comparison to non-prevascularized transplants: 
1) the absence of shrinkage resulting in an enlarged transplant size,  
2) increased collagen type I deposition,  
3) increased cell proliferation in both dermis and epidermis,  
4) minimal expression of typical wound healing markers, such as CK16 and CK17,  
5) rapid establishment of epidermal homeostasis.  
These results confirm that in vitro prevascularization greatly improves the integration, 
cell survival, and all the functional properties of the skin substitutes in vivo. In particular, the 
significantly reduced contraction of vascDESS may mean a major clinical improvement. Graft 
contraction is especially dramatic in young patients, namely in the areas of the joints, which 
forces these patients to undergo repetitive, painful surgeries, and long hospitalization. 
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Optimizing in vitro culture conditions leads to a significantly shorter production time of 
human dermo-epidermal skin substitutes (chapter 4.2) 
The main goal of the Tissue Biology Research Unit (TBRU) is to use engineered dermo-
epidermal skin substitutes clinically in an autologous and permanent fashion to treat patients 
with acute and severe skin injuries. However, the main drawback of this was initially the 
relatively long production time of 3-4 weeks [89]. Therefore, in this study I aimed at 
optimizing the standard in vitro culture conditions to shorten the production time of the skin 
grafts.  
I was able to establish a modified protocol with a significantly reduced incubation 
time of keratinocytes on the dermal template before transplantation, i.e. from 14 to 6 days. 
The obtained results clearly indicate that only 2-3 layers of keratinocytes were sufficient to 
induce a near normal, mature epidermis after transplantation. Moreover, I observed that 
cultivation of keratinocytes on dermal skin templates for longer than 6 days in vitro did not 
result in an improvement of skin barrier properties, epidermal stratification or maintenance of 
the stem cell compartment.   
To conclude, we were able to markedly shorten the total in vitro culture time from 21 
to 12 days in vitro, a finding that has an important clinical impact on the treatment of burned 
patients suffering from skin defects. 
 
“Trooping the colour” - Restoring the original donor skin color by addition of 
melanocytes to bioengineered skin analogs (chapter 4.3) 
Matching skin pigmentation has a paramount cosmetic impact after skin grafting. Even more 
importantly is sufficient skin protection against ultraviolet (UV) radiation. Hence, one of the 
major future plans of the TBRU is to tissue-engineer pigmented skin substitutes containing 
melanocytes to restore skin pigmentation or to treat severe skin disorders such as vitiligo. 
However, for the approval by the federal regulatory authority (Swissmedic) and initiation of 
phase I clinical trials, those skin substitutes need to undergo respective preclinical research. 
For this purpose initial in vivo studies were performed using the immuno-incompetent rat 
model.  
We added human melanocytes in different ratios to the epidermal compartment of 
dermo-epidermal skin analogs. Interestingly, the skin color production was independent of the 
original number of melanocytes added to the constructs, since any deviation from the 
physiological 1:5 ratio of melanocytes to keratinocytes in the basal layer, did not result in any 
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measurable “color” difference. Moreover, we observed that for the physiological restoration 
of skin pigmentation it is crucial that all three cell types - keratinocytes, melanocytes, and 
fibroblasts originate from the same donor skin.  
 
Analysis of blood and lymph vascularization patterns in tissue-engineered human 
dermo-epidermal skin analogs of different pigmentation (chapter 4.4) 
In this study I addressed another crucial issue, namely the ingrowth of blood and lymphatic 
vessels into human dermo-epidermal skin substitutes after transplantation. As our initially 
generated skin grafts are still lacking engineered blood and lymphatic capillaries, they are 
entirely dependent on the ingrowth of the patient’s vessels. If this process is insufficient, the 
long-term performance and survival of the engineered transplants will be negatively affected. 
To assess this, I investigated the blood and lymphatic vessel patterns in light- and dark-
pigmented skin substitutes at 3, 8 and 15 weeks after transplantation.  
Interestingly, all transplants were entirely vascularized already three weeks after, 
transplantation, whereas they still lacked the presence of lymphatic vessels. Overall my study 
demonstrated distinct blood vessel densities between the early (8 weeks) and late (15 weeks) 
healing stages after transplantation. Of note, similar differences were not seen with regard to 
lymph vessel ingrowth, as a comparable lymphatic vessel density was observed at 8 and 15 
weeks after transplantation, respectively.  
It can be concluded that the establishment of a rapid vascular supply within the 
transplanted skin has the highest priority with regard to immediate graft take and long-term 
survival, and therefore occurs earlier than lymphatic vessel ingrowth. Previous reports 
showed that lymphatic regeneration across scar tissues is severely impaired due to reduced 
lymphatic endothelial cell proliferation and abnormal lymphatic microarchitecture [46-47]. 
These findings are particularly important with regard to our planned clinical 
application of laboratory engineered skin substitutes. It appears tenable that a competent 
blood and lymphatic vessel supply will also develop when our skin substitutes are 
autologously transplanted onto human patients.  
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Tissue-engineered dermo-epidermal skin analogs exhibit de novo formation of a near 
natural neurovascular link 10 weeks after transplantation (chapter 4.5) 
In this study I investigated how the host-derived innervation is guided into the transplanted 
human tissue-engineered skin analogs. I expected the de novo formation of a typical 
neurovascular link and asked the question if nerve ingrowth occurs alongside host blood or 
lymphatic vessels.  
As mentioned above the growth dynamics of blood capillaries on the one hand, and 
lymphatic capillaries on the other hand, are fundamentally different. We have shown 
previously that a vascular network can be spontaneously established by neovascularization as 
early as three weeks post-transplantation. However, reasonable innervation of the dermal 
compartment is present only after eight weeks [54]. Certainly, early vascularization of a 
transplanted skin analog by capillaries and larger blood vessels is crucial to ensure sustained 
graft take and long-term survival and has therefore the highest physiological “priority” 
regarding the establishment of host structures within the transplanted tissue. In contrast, 
lymphatic vessels and nerve fibers are not indispensable for graft survival during the early 
stage after transplantation.  
I could convincingly demonstrate that 10 weeks after transplantation a de novo formed 
neurovascular link was present in the dermal compartment with a typical alignment between 
blood vessels and nerve fibers as seen in typical neurovascular links. On the other hand, such 
a relationship could not be demonstrated between lymphatic vessels and nerve fibers in this 
setting. 
 
 
All experimental studies presented in this thesis describe crucial requirements to make the 
clinical application of tissue-engineered autologous human skin grafts feasible. I was able to 
essentially improve the in vitro production process and characterize distinct in vivo 
regeneration steps in our preclinical studies. 
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7. ABBREVIATIONS 
 
BSA Bovine serum albumin 
CD Cluster of differentiation 
CK Cytokeratin 
DAPI 4',6-diamidino-2-phenylindole 
DESS Dermo-epidermal skin substitutes 
DMEM Dulbecco’s Modified Eagle Medium 
FCS Fetal calf serum 
FdA Fluorescein diacetate 
FITC Fluorescein iso-thiocyanate 
H&E Haematoxylin & Eosin 
PBS Phosphate buffered saline 
PE Phosphate buffered saline 
TBSA Total body surface area 
TBRU Tissue Biology Research Unit 
TE Tissue engineering 
TRITC Tetramethyl rhodamine iso-thiocyanate 
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